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ABSTRACT  
 
Cardiovascular events are a leading cause of death in western countries. Cardiovascular diseases 
also increase health care costs in that way also increasing the national economic burden. Obesity 
and hypertension are major risk factors for cardiovascular diseases. These diseases are affected not 
only by genetic factors but also by dietary factors especially the high salt and high fat diet typical 
in industrialized societies today. Endothelial dysfunction is a feature of many different 
cardiovascular diseases and endothelial dysfunction is now regarded as an early marker of 
atherosclerosis.The molecular mechanisms of endothelial dysfunction are still poorly understood. 
The present series of studies was carried out in order to investigate the mechanisms of vascular 
dysfunction in mice diet-induced hypertension and obesity.  Furthermore, special emphasis was 
placed on endothelial function, reactive oxygen species (ROS) formation and periadventitial 
adipose tissue (PVAT) to target underlying molecular mechanisms. In the experimental 
hypertension studies, two atherosclerotic mice models, apolipoprotein E-deficient (ApoE-/-) and 
low-density-lipoprotein receptor knockout mice (LDLR-/-) were  fed high salt and normal salt diets 
while C57Bl/6 mice served as littermate controls.  In the obesity studies, C57Bl/6 mice were used as 
models for diet-induced obesity. The effect of weight loss was investigated by challenging a 
subgroup of obese C57Bl/6 mice on caloric restriction (CR). Our findings indicate that 1)  high salt 
intake had an important effect on arterial pressure, vascular oxidative stress and endothelial 
dysfunction which increase the progression of atherosclerosis in two atherosclerotic mice models, 
2) the aggravating effects of obesity on endothelial dysfunction and vascular oxidative stress are to 
a great extent improved by CR, preventing uncoupling of eNOS and improving oxidative stress 3) 
PVAT plays an important role in the pathogenesis of obesity-induced endothelial dysfunction by 
promoting oxidative stress and augmenting proinflammatory adipocytokine production. 
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Ketonen, Juha. Verisuonen toimintahäiriö hiiren ravintoperäisessä verenpainetaudissa ja 
lihavuudessa. Endoteelin, reaktiivisten happiradikaalien ja verisuonta ympäröivän rasvakudoksen 
merkitys.  Itä-Suomen yliopiston julkaisuja. Terveystieteiden tiedekunnan väitöskirjat. 23, 2010.91s. 
 
TIIVISTELMÄ 
Sydän-ja verisuonisairaudet ovat keskeinen sairausryhmä, jolla on merkittävä vaikutus 
sairastuvuuteen ja kuolleisuuteen maailmanlaajuisesti.  Sydän- ja verisuonisairaudet ovat myös 
merkittävä kansantaloudellinen ongelma, joka aiheuttaa julkisen terveydenhuollon  kustannusten 
kasvua vuosittain. Endoteelisolukerroksen toimintahäiriö nk. endoteelidysfunktio on tärkeä ja 
aikainen tapahtuma verisuonisairauksissa. Tässä väitöskirjatyössä tutkittiin miten verisuonen 
toimintahäiriö kehittyy hiiren kokeellisissa verenpainetaudin ja lihavuuden malleissa. Tässä 
väitöskirjatyössä koe-eläimille syötettiin runsassuolaista ja runsasrasvaista dieettiä, jonka avulla 
pyrittiin mallintamaan ihmisen verenpainetautia ja lihavuutta. Verisuonen toimintaa mitattiin koe-
eläimistä eristetyillä verisuonen rengasmaisilla näytteillä sileälihashauteessa, jossa verisuonen 
supistuvuutta ja relaksaatiota tutkittiin. Verisuoninäytteistä tutkittiin lisäksi happiradikaalien 
tuotantoa, ateroskleroosin astetta, verisuonen seinämän rakenteen muutoksia ja 
perivaskulaarirasvan määrää. Tämän väitöskirjan tärkeitä havaintoja olivat: 1) runsassuolainen 
ruokavalio lisäsi ateroskleroosin määrää ateroskleroottiseen sairauteen perinnöllisesti taipuvaisilla 
apolipoproteiini E-poistogeenisillä ja LDL-reseptoripoistogeenisillä hiirillä; 2) energian saannin 
rajoitus paransi endoteelin häiriintyneen toiminnan lihavilla villintyypin C57Bl/6 hiirillä ja vähensi 
reaktiivisten happiradikaalien, superoksidien määrää verisuonen seinämässä; 3) 
perivaskulaarirasvan määrä oli merkittävästi kasvanut sekä perivaskulaarirasvan normaali 
verisuonen supistuvuutta alentava vaikutus oli heikentynyt lihavilla villintyypin C57Bl/6 hiirillä. 
Lihavien koe-eläinten perivaskulaarirasva ilmensi voimakkaasti tulehduksellisia sytokiinejä ja 
NADPH-oksidaasia, jonka tiedetään olevan keskeinen entsymaattinen lähde hapen 
radikaalituotannolle. Tässä väitöskirjassa saadut tulokset vahvistavat viimeaikaisia käsityksiä sekä 
suolan saannin merkityksestä että painonhallinnan tärkeydestä sydän- ja verisuonitautien 
ehkäisyssä ja hoidossa.  
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1 Introduction 
Cardiovascular diseases are important global causes for morbidity and mortality. Cardiovascular 
diseases are highly associated to environmental factors, only 1 % of all morbidities are explained 
by direct genetic defects. In fact, environmental factors such as diets have an enormous impact on 
hypertension, diabetes, obesity and hypercholesterolemia in high risk patients (Sanchez-Tainta et 
al. 2008).  
 
Compelling evidence from human and animal studies demonstrates that a high salt intake is 
associated with increased risk of total cardiovascular diseases (Meneton et al. 2005; Strazzullo et al. 
2009). A high dietary salt intake in the form of sodium chloride is an important etiological cause of 
essential hypertension which is diagnosis given to 95% of hypertensive patients (Meneton et al. 
2005). Reducing the sodium intake attenuates arterial pressure both in normotensive and 
hypertensive subjects as well as reducing mortality for stroke and  coronary heart disease (Franco  
& Oparil  2006; Karppanen  & Mervaala  2006). On the other hand, a high sodium intake has 
detrimental impact on cardiovasculature also via pressure-independent effects (Simon 2003; 
Frohlich  & Varagic  2005).  Finally, the cardiovascular benefits of reduced salt intake are on a par 
with the benefits of population-wide reductions in tobacco use, obesity, and cholesterol levels 
(Bibbins-Domingo et al. 2010).  
 
Obesity, which is often attributable to increased energy intake  from saturated fat, is now regarded 
as a risk factor for cardiovascular diseases since it predisposes to metabolic syndrome i.e. increased 
arterial pressure, fatty liver, dyslipidemia, prothrombotic state,  glucose intolerance and visceral 
adipose tissue accumulation (van Gaal  et al. 2006; Meyers & Gokce 2007; Bogaert & Linas 2008). 
Adipose tissue dysfunction is believed to be one of the primary defects in obesity and it may link 
obesity to several cardiovascular disorders (Bluher 2009; Shimabukuro 2009). There is 
accumulating experimental evidence that PVAT is a novel regulator of vascular function through 
production and secretion of vasoactive substances (Rajsheker et al. 2010). Thus, both functional 
and structural alterations in this specific fat depot during weight gain may affect also the 
functional   integrity of blood vessels.   
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Endothelial cell (EC) dysfunction represents the earliest abnormality in the development of 
atherosclerotic vascular disease (Meyers and Gokce 2007). There is an increasing body of evidence 
indicating that endothelial dysfunction might be an independent predictor for the risk of future 
cardiovascular events (Yoshida et al. 2006; Versari et al. 2008). Oxidative stress and low grade 
inflammation contribute to endothelial dysfunction but are also important key factors in the 
various pathological events of atherosclerosis including vascular remodelling, inflammation, 
apoptosis and proliferation and growth of VSMCs (Ardanaz & Pagano 2006). Therefore, a better 
understanding of the molecular mechanisms predisposing to endothelial dysfunction and vascular 
damage is a crucial element in the prevention and treatment of atherothrombotic cardiovascular 
diseases. 
 
The present study was intended to clarify the underlying molecular mechanisms of vascular 
dysfunction in experimental hypertension and obesity.  ApoE-/- mice and LDLR-/- were fed high salt 
diets and used as murine models for human atherosclerosis. Obesity was induced by feeding 
C57Bl/6 mice with a high fat diet, a murine model of human type obesity. Moreover, special 
emphasis was placed on endothelium, ROS and PVAT to clarify the vascular pathogenesis in 
experimentally induced hypertension and obesity.  
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2 Review of the Literature 
2.1 THE NORMAL ARTERY 
2.1.1 Endothelium 
ECs form the tunica intima, a thin monocellular layer that covers the inner surface of the entire 
vascular system (figure 1). The endothelium can be assessed via cell count (1 to 6 x 1013 cells), mass 
(~1 kg), or surface area (1000 m2) (Florey 1966; Cines et al. 1998).  ECs represent the interface of 
blood and the vascular wall. These cells are involved in different physiological functions, 
including metabolism, angiogenesis, hemostasis, inflammation, synthesis and degradation of the 
extracellular matrix as well as regulating vascular permeability and tone (Feletou & Vanhoutte 
2006). The endothelium controls the balance between 1) inhibition and promotion of the 
proliferation and migration of smooth muscle cells; 2) prevention and stimulation of the adhesion 
and aggregation of the platelets; 3) trombogenesis and fibrinolysis 4) vasodilatation and 
vasoconstriction (Feletou & Vanhoutte 2007). In addition to possessing an important barrier 
function, the endothelium promotes also active transvascular diffusion, communicating with 
VSMCs via myoendothelial gap junctions that allow not only the spread of electronic tone but also 
the transfer of ions and small molecules e.g. calcium (Ca2+) and cyclic nucleotides (Feletou & 
Vanhoutte 2007). The EC responds to certain mechanical factors such as fluid, shear stress and 
stretch. These factors are sensed by the EC to modify intracellular signalling, gene expression, and 
protein expression resulting in functional regulation (Esper et al. 2006).  
 
2.1.2 Smooth muscle cells 
The internal elastic lamina separates the intima from the middle layer in blood vessels called, 
tunica media. This contains principally smooth muscle cells arranged in layers (figure 1). An 
extracellular matrix consisting largely of elastic fibres and collagen with a lesser content of 
proteoglycans holds the smooth muscle cells together.  The  enhanced content of elastin is a 
common feature in the  larger conduit arteries that act as capacitance vessels between ejections of 
blood from the heart whereas more peripheral arteries acting as resistance vessels typically possess 
vast numbers of smooth muscle cells in order to regulate blood pressure changes. Vascular tone is 
dictated by the reactivity of plasmalemmal of vascular smooth muscle cell which  is the ultimate 
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target of many biological signalling molecules, circulating hormones and neurotransmitters 
influencing  ion channels, G-protein coupled receptors and other cellular signalling pathways 
(Stocker &  Keaney  2004).  
 
2.1.3 Adventitium 
The tunica adventitia is the outermost layer of the vascular wall and usually consists of a loose 
matrix of elastin, smooth muscle cells, fibroblasts, and collagen (figure 1; Stocker & Keaney 2004). 
A major part of central nervous system mediated arterial tone regulation is directed through this 
layer.  For long, the adventitia was considered a rather passive structure without any relevance to 
vascular biology. However, according to accumulating evidence, the adventitia is now considered 
to play significant role in vasomotion, vascular proliferation, hypertrophy and atherosclerosis 
largely due to its high capacity for generating vascular reactive oxygen radicals (Pagano & 
Guttermann 2007).   
 
2.1.4 Periadventitial adipose tissue 
PVAT is distributed widely throughout the arterial circulation with the exception of some portions 
of central nervous system (figure 1; Guzik et al. 2007). Anatomically, PVAT is located in close 
proximity to the vascular wall of the rat aorta, i.e. a distance of only 50-100 µm (Henrichot et al. 
2005). PVAT consists of both brown and white adipocytes in addition to capillary endothelial cells, 
fibroblasts and macrophages. Consequently, PVAT has an active renin-angiotensin system as well 
as functional endothelial NO synthase (Bujak-Gizycka et al. 2007). Very recently, PVAT was found 
to modulate vascular structure and function. In clinical studies, vascular grafts harvested 
atraumatically saving the PVAT depot show improved patency compared to grafts without PVAT 
(Dashwood et al. 2007). On the other hand, obesity is associated with enhanced fat deposits within 
and around tissues and organs.  In obese and aged rats, the amount of PVAT is augmented and its 
function is also altered. The enhanced fat surrounding the aortas of obese rats promotes VSMC 
proliferation as well as the generation and secretion of chemokines which lead to the accumulation 
of inflammatory cells (Barandier et al. 2005; Henrichot et al. 2005). Collectively, the interplay 
between PVAT and other layers of vascular wall has a major role in the balance between health               
and disease in blood vessels.                                                 .                           
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Figure 1. Schematic depiction of structural and functional changes of the different layers of the vascular wall in diseased 
arteries. (Modified from Heistad et al. 1995)
Endothelial cells Smooth muscle cells
Adventitial cells
Hypertension
Normal artery
Atherosclerosis Obesity
Periadventitial adipose tissue
-increased fat/cholesterol accumulation
into subendothelial space
- occlusion of arterial lumen
-increased smooth muscle cell
hypertrophy
- enhanced arterial lumen narrowing
-increased perivascular fat
-enhanced inflammatory cell and 
ROS production by perivascular fat
 6 
2.2 REGULATION OF ARTERIAL TONE 
 
Arterial tone is determined by the balance between vasodilatation and vasoconstriction of the 
VSMC. The endothelium has a dual function in the control of arterial tone, secreting both relaxing 
factors (nitric oxide (NO), prostacyclin (PGI2), hyperpolarizing factors) and constricting factors 
(angiotensin II (Ang II), endothelin-1 (ET-1) and prostaglandin (PG) F2α, thromboxane A2 and 
superoxide) in response to different stimuli such as mediators released from autonomic and 
sensory nerves or platelets, circulating hormones, autacoids, cytokines and drugs as well as 
physical and chemical stimuli (Gryglewski et al. 1986; Lüsher et al. 1987; Lawson et al. 1990; Nagao 
& Vanhoutte 1992; Dai et al. 1992; Shimokawa et al. 1996; Fleming & Busse 1999). Vessel tone is 
dependent on the balance between these factors as well as the ability of the VSMC to respond to 
them (Vanhoutte 1989). The normal endothelium maintains arterial tone and blood viscosity, 
prevents abnormal blood clotting and bleeding, limits inflammation of the vasculature, and 
suppresses smooth muscle cell proliferation (figure 2). The abnormal endothelium causes 
increased inflammation and hypertrophy of the smooth muscle cells, promotes thrombosis and 
vasoconstriction, and creates a situation ripe for the establishment and rapid growth of 
atherosclerotic plaques. With respect to the physiological function of different size of arteries, 
defects in endothelial regulation in the large conduit arteries result in arterial stiffness which in 
turn enhances the cardiac work load during the systole. Moreover, disruption of endothelium 
integrity in peripheral arteries contributes to abnormal vasormotor tone and contributes to 
increased blood pressure. 
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Figure 2. Production of vasodilatory and contractile factors in the arterial wall and their effects on vascular tone (modified from 
Vanhoutte 2001; Gao et al. 2007b)  AA = arachidonic acid; AC = adenylate cyclase; ACE = angiotensin converting enzyme; ADRF = adipocyte derived relaxing factor; 
AngI = angiotensin I; [Ca2+]i = intracellular calcium concentration; cAMP = cyclic adenosine monophosphate; cGMP = cyclic guanosine monophosphate; COX = cyclo-oxygenase; 
ECE = endothelin converting enzyme; EDHF = endothelium derived hyperpolarizing factor; GTP = guanosine triphosphate; IP3 = inositol triphosphate; NO = nitric oxide; PGH2 
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reactive oxygen species; sGC = soluble guanylate cyclase; TXA2 = thromboxane A2, IP/TP/FP = receptor for prostaglandins
E
n
d
o
th
e
li
u
m
[Ca2+]i
S
m
o
o
th
m
u
sc
le
ce
ll
RELAXATION
COX
NOS
EDHF
ACE ECE COX
PLA2
ROS
AA PGI2
L-arg NO
IP sGC
K+
Hyperpolarization
GTP cGMP
AC
ATP cAMP
AngI
AngII
Big-ET-1
ET-1
AA PGH2
PGF2a
TXA2
AT2
AT1 ETA
TP/FP
PKC
PLC
PI IP3 [Ca2+]i
CONTRACTION
P
er
ia
d
v
en
ti
ti
a
l
ad
ip
o
se
ti
ss
u
e
ADRF
ROS
 8 
2.2.1 Endothelium-derived contractile factors 
2.2.1.1  Angiotensin II 
Ang II has a major physiological significance in the cardiovascular system through its role in 
maintaining vascular tone and increasing myocardial activity; stimulating the synthesis and 
release of aldosterone and increasing sodium (Na+) reabsorption  thereby influencing blood volume 
and thirst; maintaining sympathetic outflow to the vasculature and in autoregulating cerebral 
blood flow (Mehta & Griendling 2007). Pathological Ang II induced signalling in vascular, 
endothelial and cardiac cells promotes ROS production, inflammation, platelet activation, altered 
vasoreactivity, growth, migration and fibrosis. Ultimately these all combine to cause serious 
diseases such as hypertension, atherosclerosis, restenosis after angioplasty,  heart failure, chronic 
kidney disease, insulin resistance and tumor progression. The improved clinical outcomes after 
treatment with angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor-1 (AT1) 
blockers confirm  the importance of Ang II in the pathogenesis of these diseases (Cheng et al. 2005; 
Mehta & Griendling 2007; Fyhrqvist & Saijonmaa 2008). 
 
ACE1 is expressed in  animal and human endothelium (Fukuhara et al. 2000; Akishita et al. 2001) 
Ang II is formed from the enzymatic cleavage of angiotensinogen to Ang I by  renin with the 
subsequent conversion of Ang I to Ang II by ACE1.  The vascular contractile response to Ang II is 
mediated via AT1 receptors  in VSMC. Ang II promotes vasoconstriction  by the  production of free 
oxygen radicals and through the cyclooxygenase-1 (COX-1) dependent formation of contractile 
prostanoids (Lu et al. 2008a; Jerez et al. 2008).  Ang II exerts actions also via AT2 receptors which in 
contrast to AT1 receptors are primarily expressed in endothelium (Stennet et al. 2009).  AT2 is 
thought to mediate effects opposing and counterbalancing those mediated via AT1. There are also  
several other angiotensin fragments with potential biological effects but these properties are less 
well understood as compared with Ang II. For example, Ang III is generated from Ang II by 
aminopeptidase A and this fragment can act upon  AT1 and AT2 receptors (Zini et al.1996). Ang IV  
is generated in part by aminopeptidase M and it exerts on AT4 receptor (Vanderheyden 2009). 
Ang(1-7) is generated by ACE2 from  Ang II  (Ferrario 2006).  Ang(1-7) is abundantly expressed 
and continuously released from the PVAT of rat aorta (Lee et al. 2009). Ang(1-7) acts on the 
endothelial mas receptor and promotes vasodilatation through activating calcium-activated 
potassium channels in the VSMC and via endothelial NO formation, at least  in aortic preparations. 
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2.2.1.2  Endothelin-1 
The 21-amino acid peptide, ET-1, is regarded as the most prominent isoform of the three ET 
isopeptides, in the cardiovascular system, accounting for the majority of vasoactive effects elicited 
by ETs. The secretion of ET-1 by ECs is regulated at the level of peptide synthesis because these 
cells do not contain secretory granules for storage and later release of ET.  Mature ET-1 is formed 
from pre-pro-ET-1 via a 39-amino acid intermediate, big ET-1. Big ET-1 is processed to ET-1 by a 
family of ET converting enzymes and other enzymes such as chymases, non-ECE 
metalloproteinases and endopeptidases.The biological effects of ET-1 are transduced by two 
pharmacologically distinguishable receptor subtypes ETA and ETB. In the vasculature, ET-1 
stimulates directly  the ETA receptor in the VSMC and also indirectly activates endothelium-
dependent production of TXA2, thereby leading to vasoconstriction (Itoh et al. 1988; Böhm & 
Pernow 2007).  
 
The binding of ET-1 to the receptor activates the phospholipase C which hydrolyzes phosphatidyl 
inositol-4,5-biphosphate into two products inositol triphosphate and diacylglycerol. This event 
results in a rapid increase in the intracellular Ca2+ concentration ([Ca2+]i).  which is further 
augmented by opening of the L-type Ca2+ channels leading to influx of extracellular Ca2+  and 
ultimately to vasoconstriction (Ortega & de Artinano 1997; Kawanabe & Nauli 2005). Additionally, 
ET-1 stimulates also endothelium-derived ETB receptor which activates the production of NO and 
PGI2,  thereby promoting vasodilatation. Therefore, the balance between activated ETA and ETB 
receptors plays an important regulatory role in determining the the cardiovascular effects of ET-1. 
 
Endogenous ET-1 has a physiological role in the maintenance of vascular tone and cardiac function 
in healthy humans (Kedzierski & Yanagisawa 2001). It increases the heart rate and stroke volume 
as well as causes potent and long lasting vasoconstriction in pulmonary, renal splanchnic, 
myocardial and skeletal muscle vasculature. Increased vascular sensitivity to ET receptor 
stimulation is present in patients with hypertension and atherosclerosis. ET-1 induces endothelial 
dysfunction and oxidative stress through enhancing the production of free oxygen radicals and 
augmenting the activity and/or expression of proinflammatory and proatherosclerotic events 
(Böhm & Pernow 2007; Mundy et al. 2007).  
 
 10 
2.2.1.3 Cyclooxygenase-derived contractile factors 
The endothelium generates various types of potent contractile prostaglandins (PG) and 
thromboxane including prostaglandin H2 (PGH2), thromboxane A2 (TXA2) and PGF2α (Kato et al. 
1990; Fujiwara et al. 1992; Gluais et al. 2005). The formation of these potent lipid signalling 
molecules, also called prostanoids, is principally catalyzed from cell membrane-derived 
arachidonic acid by two isoforms of COX. In EC, COX-1 is constitutively active whereas COX-2 
expression can be markedly induced by proinflammatory cytokines. The most important 
difference between these two isoforms is that COX-2 has a lower threshold for activation and a 
higher capacity to synthetizise prostanoids as compared with COX-1. Nevertheless, both isoforms 
of the COX enzyme generates contractile prostanoids that are believed to be involved in the 
physiological control of  resting vascular tone and regulation of arterial pressure through a delicate 
interplay with the endothelium-derived vasodilator NO. In mouse abdominal aorta,   COX-1 
dependent vasoconstriction is can be occasionally observed under stimulated NO release at high 
concentrations of acetylcholine (Zhou et al. 2005). In rat isolated vascular segments, blockade of 
NO synthesis by L-NAME can augment vasoconstriction and increase blood pressure effects which 
are restored by treatment with celecoxib, a selective inhibitor of COX-2 (da Cunha et al. 2002). 
There is a substantial amounts of evidence from experimental models of genetic hypertension 
(Lüscher & Vanhoutte 1986); salt-sensitive hypertension (Zhou et al. 2003); streptozocin induced 
type 1 diabetes (Shimizu et al. 1993)  and obesity (Traupe et al. 2002a)  to suggest that in these 
conditions in which there is deficient NO bioavailability, COX-dependent vasoconstrictors become 
predominant, contributing to vascular dysfunction. 
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2.2.2 Contractile responses ex vivo 
2.2.2.1 Adrenergic agonists 
Noradrenaline (NA) and phenylephrine (Phe) are the most widely used preconstricting agents in 
the study of endothelial dependent and –independent relaxation responses in isolated blood 
vessels (Faraci & Sigmund 1999). They exert a well-sustained contractile response by activating α1-
adrenoceptors though in some vascular beds, perhaps depending on the concentration, NA may 
also bind to α2-receptors and induce vasodilatation through NO production. The main mechanism 
for α1- agonist-mediated vasoconstriction involves the release of Ca2+ from the sarcoplasmic 
reticulum and subsequent depolarization by activation of chloride (Cl-) channels. This results in 
augmented extracellular Ca2+ influx through voltage gated L-type Ca2+ channels in the plasma 
membrane of the VSMC  i.e. overall  increase in [Ca2+]i and a subsequent contractile response (van 
Breemen et al. 1986; Karaki 1987; Mironneau & Macrez-Leprêtre 1995). 
 
2.2.2.2 Potassium chloride 
High concentrations (> 30 mM) of potassium chloride (KCl) exert vasoconstrictive effects through 
membrane depolarization, releasing noradrenaline from nerve endings and inhibiting Na+K+ 
ATPase (Rapoport et al. 1985; Xiao & Rand 1991). Agonist-induced contractile responses are 
frequently compared with the contraction induced by KCl which is used to standardize the 
maximum force generated by VSMC in isolated blood vessels. However, low concentrations of KCl 
(5-25mM) are able to induce hyperpolarization and thereby cause vasodilatation in small resistance 
arteries (Edwards et al. 1998). 
 
2.2.3 Endothelium-derived vasodilatory factors 
2.2.3.1 Nitric oxide 
Endothelum-derived NO is a critical regulator of cardiovascular homeostasis. In addition to its 
pivotal role in the maintenance of vascular tone, NO has additional major effects on 
neurotransmitter function in both the central and peripheral nervous systems and is involved in 
the mediation of cellular defence. In addition, NO interacts with mitochondrial systems to regulate 
cell respiration and to augment the generation of reactive oxygen species (ROS), thus triggering 
mechanisms of cell survival or death. Moreover, NO is now considered as a major 
antiatherosclerotic molecule based on its anti-inflammatory, antiapoptotic, antiplatelets and  
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antiproliferative properties. NO has been implicated in a number of cardiovascular diseases and 
virtually every risk factor for these diseases appears to be associated with a reduction in 
endothelial generation of NO (Fleming & Busse 1999; Moncada & Higgs 2006; Pechanova & Simko 
2007).  
 
The free radical NO is generated exclusively by the enzyme NO-synthase (NOS). Three isoforms of 
NOS have been identified: neuronal (nNOS) or NOSI, inducible (iNOS) or NOSII and endothelial 
(eNOS) or NOSIII. nNOS is expressed in neurons and eNOS is expressed in ECs, cardiac myocytes 
and blood platelets. The expression of iNOS is not constitutive, instead it is induced by various 
cytokines. In the vasculature, the signalling cascade starts with eNOS which generates NO and L-
citrulline from L-arginine, O2 and NADPH in response to receptor-dependent agonists and 
physicochemical stimuli. The cofactors that are required for NO generation are (6R)-5,6,7,8-
tetrahydro-L-biopterin (BH4), flavin adenine dinucleotide and flavin mononucleotide. 
Furthermore, the enzyme contains binding sites for heme and calmodulin, both of which are 
essential for enzyme activity (Govers & Rabelink 2001; Fleming & Busse 1999). The NO mediated 
nitrosative reaction with thiol groups is proposed as a natural storage of NO (Mateo & de 
Artenano 2000). Interestingly, independently of the enzyme control of NOS mediated NO 
synthesis, endothelial and VSMCs possess stores of NO that, in part, exist in the form of S-
nitrosoglutathione (Rodriquez et al. 2003; Ng et al. 2007). These additional stores are activated in 
response to UV-light and chemical stimuli, at least under experimental conditions. Although the 
specific locations for these stores are unclear it has been suggested that they could serve as an 
additional mechanism for the regulation of vascular tone. 
 
eNOS derived NO binds guanylate cyclase (GC) in VSMC which leads to the subsequent formation 
of cyclic guanosine-3´-5´monophosphate (cGMP) thereby evoking vasodilatation. The cGMP thus 
formed acts as a second messenger activating cGMP dependent protein kinases and this facilitates 
the phosphorylation of various proteins as well as vasorelaxation. The increase in cGMP levels and 
the consequent activation of GMP dependent kinases reduces [Ca2+]i by different mechanisms. 
These mechanisms include phosphorylation of phospholamban which in turn produces an 
activation of the Ca2+ -adenosine triphosphatase (ATPase) in the sarcoplasmic reticulum; 
stimulation of Ca2+ extrusion from inside the EC as a result of Na+/ Ca2+ exchanger activation; 
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inhibition of Ca2+ L-type channels; inhibition of the release of Ca2+ from intracellular stores and 
prevention of the formation of inositol triphosphate (IP3); opening and activation of potassium (K+) 
channels and, under certain conditions, inhibition of cyclic 3´,-5´- adenosine monophosphate 
(cAMP) phosphodiesterase (Mateo & de Artenano 2000). 
 
The molecular structure of NO with one unpaired electron in the highest orbital means that it is a 
free radical, reacting rapidly with other molecules that contain unpaired electrons. The reaction of 
NO with the haem group of haemoglobin which acts as an intravascular scavenger is the principal 
metabolic pathway for removal of endogenous NO. NO is rapidly removed by its rapid diffusion 
through tissues into red blood cells where it is rapidly converted to nitrate by the reaction with 
oxyhemoglobin. This limits the biological half-life of NO in vivo to less than a second whereas the 
concentrations of NO relevant for cellular signalling can persist in phosphate buffer saline for one 
hour. On the other hand, and equally important, when both superoxide and NO are synthesized 
within a few cell diameters of each other, these compounds can combine spontaneously to form 
peroxynitrite in a diffusion limited reaction (Pacher et al. 2007; Mateo & de Artenano 2000). 
Endothelial dysfunction is to a large part defined as impaired endothelium-dependent NO-
mediated vasodilatation, due to high levels of concomitantly generated superoxide. 
 
2.2.3.2 Prostacyclin  
Since the advent of non steroidal anti-inflammatory drugs and their potential adverse side-effects 
on the cardiovasculature, the biology of PGs  has been an intense field of scientific research. In 
response to blood flow-related mechanical forces and circulating hormones, PGI2 is the main 
metabolite of arachidonic acid enzymatically converted by COX-1 and released in the ECs (Dusting 
et al. 1977; Weksler et al. 1977). PGI2 is a predominant agonist for cell surface receptor IP whereby 
there is some evidence to suggest an involvement of cytosolic coupling to intracellular peroxisome 
proliferator-activated receptor β (PPARβ). (Breyer et al. 2001; Davidge 2001). Stimulation of IP 
receptors in VSMC and platelets leads to activation of adenylate cyclase which produces high 
concentrations of cyclic AMP (Swartz et al. 2001; Mitchell et al. 2008). These events goes on to  
phosphorylation of  protein kinase A (PKA) which results ultimately in a reduction of the  [Ca2+]i in 
most target cells. As a consequence, PGI2 exerts antiplatelet actions, evokes vasodilatation, causes a 
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reduction in VSMC remodelling and cholesterol uptake all of which contribute to its 
cardioprotective effects (Nakayama et al. 2006). 
 
2.2.3.3 Endothelium-dependent hyperpolarization 
Endothelium-dependent hyperpolarization of the VSMC is a powerful means for vasodilatation as 
demonstrated in animal and human studies (Shimokawa et al. 1996; Urakami-Harasawa et al. 
1997). Endothelium-dependent hyperpolarization is commonly thought to be pronounced when 
there is a decrease in the diameter of arteries. This has been demonstrated both in preclinical and 
clinical studies. However, according to recent findings, nNOS-derived hydrogen peroxide is an 
important mediator of hyperpolarization in mouse large conduit arteries (Capettini et al. 2008).  
The relaxation response obtained after concomitant pharmacological blockade of both NOS and 
COX is usually referred to endothelium-dependent hyperpolarization (Feletou & Vanhoutte 2007). 
The term endothelial derived hyperpolarizing factor, EDHF, refers to virtually any biologically 
active compound that is generated and released from endothelium leading to vasodilatation by 
hyperpolarization of plasma membrane of  VSCM. Activation of several types of K+ channels in the 
VSMC predominantly mediates endothelium-dependent hyperpolarization. These channels 
include calcium-activated (KCa), sarcolemmal ATP-sensitive  (KATP), inward rectifier (Kir) and 
voltage-dependent  (KV)  (Ko et al. 2008). There are many other potential compounds, eg. 
endothelium-derived NO, epoxyeicosatrienoic acids, CO and H2O2 which activate   large-
conductance KCa (BKCa) channels expressed in VSMC (Félétou 2009). In contrast to BKCa channels, 
intermediate (IKCa) and small conductance K+ channels (SKCa) are expressed in endothelium. In 
addition to evoking endothelium-dependent hyperpolarization, these K+ - channels are involved in 
the regulation of Ca2+ -sensitive enzyme such as NOS as well as  in the generation of NO (Sheng & 
Braun 2007).  
 
2.2.4 Dilatory responses ex vivo 
2.2.4.1  Endothelium-dependent relaxation response 
Acetylcholine (Ach) is the classical compound exerting endothelium-dependent vasodilatation due 
to stimulation of muscarinic (M) receptors in the presence of an intact endothelial cell layer. Ach 
binds to M1- M5 receptors though only the stimulation of the M3 receptor subtype leads to the 
endothelium-derived  liberation of NO, PGI2  and also opening  of the K+ channels in the 
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plasmalemmal of VSMC thereby leading to  hyperpolarization. (Beny et al. 2008; Walch et al. 2001). 
However, Ach can cause also endothelium-dependent and independent contractions due to release 
of TXA2 and direct actions on M3 receptors located at VSMCs, respectively (Kirkpatrick et al. 2001). 
  
2.2.4.2  Endothelium-independent relaxation response 
Nitrates are pivotal anti-ischemic and anti-anginal agents widely used for treating symptoms in 
patients with acute myocardial infarction and chronic congestive heart failure (Abrams 1996). 
Nitrovasodilators including sodium nitroprusside (SNP), S-nitroso-N-acetylpenicillamine (SNAP) 
or 3-morpholinosydnonimine (SIN-1) are also used to achieve endothelium-independent 
vasodilatation and to confirm the integrity of VSMC in organ bath studies. Generally, exogenous 
administration of nitrates is thought to act through the same signalling pathway as NO generated 
by eNOS. Consequently, these compounds are metabolized during their interaction with the 
vascular wall and they activate GC by both NO dependent and independent pathways. The 
activation of GC results in  relaxation  via the formation of cGMP and subsequent K+ efflux by 
opening of Ca2+ activated K+ channels (Carrier et al. 1997; Schrammel et al. 1998). 
 
2.3 PERIADVENTITIAL ADIPOSE TISSUE-DERIVED VASOACTIVE FACTORS 
  
PVAT is a unique fat depot. In particular, perivascular adipocytes are not demarcated by a fascial 
layer or elastic lamina, instead perivascular adipocytes reside in the close vicinity of  the outer 
adventitial  vascular wall (Chatterjee et al. 2009; Shimabukuro 2009). Thus, this  important 
anatomic feature means that they have  a free pathway  to influence vascular function via 
paracrine mediators. PVAT exerts anticontractile and/or vasodilator effect through stimulation of 
endothelium-dependent NO production and via opening of various K+ channels in plasmalemmal 
of VSMC in mouse, rat and human arteries (Soltis & Cassis 1991; Löhn et al. 2002; Verlohren et al. 
2004; Dubrovska et al. 2004; Gao et al. 2005a; Gao et al. 2007a). Very recently,  Ang(1-7) and 
gaseous hydrogen sulphide have been identified as significant adipose tissue derived relaxing 
factors, ADRFs (Lee et al. 2009; Fang et al. 2009). The degree of vasodilatation correlates with the 
amount of PVAT. Both lipoathropic and spontaneously hypertensive (SHR) rats have impaired 
PVAT function due to decreased amount of PVAT. On the contrary, prenatally nicotine-exposed 
obese rats have an increased amount of PVAT associated with blunted vasodilator effects (Gao 
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2005b, Galvez et al. 2006; Takemori et al. 2007). Furthermore, PVAT is also an important site for 
local effects from proatherosclerotic and proinflammatory agents. The amounts of released PVAT 
derived harmful biologically active substances are markedly elevated in in the murine models of 
human obesity (Barandier et al. 2005; Heinrichot et al. 2005). Therefore, alterations in the paracrine 
role of PVAT might have a role in hypertension and metabolic diseases promoting endothelial 
dysfunction (Montani et al. 2004; Yudkin et al. 2005).  
 
2.4 ENDOTHELIAL DYSFUNCTION AND DIET   
 
The normal endothelium maintains the balance between vasodilatation and vasoconstriction that 
determines the arterial diameter thereby influencing blood pressure control (Félétou & Vanhoutte 
2006). With respect to cardiovascular disorders, endothelial dysfunction is observed   even before 
any permanent morphological or structural alterations such as intimal hyperplasia or  lipid 
deposition can be detected in the vessel wall. (Cohen et al. 1988; Förstermann et al. 1988; Panza et 
al. 1990; Nitenberg et al. 1993; Reddy et al. 1994). Endothelial dysfunction has a systemic nature 
occurring both in peripheral and conduit  arteries as well as in epicardial coronary arteries in 
clinical patients (Wu et al. 2007).  Furthermore, the occurrence of endothelial dysfunction is equal 
to the number of traditional cardiovascular risks in clinical patients (Davignon & Ganz 2004; 
Versari et al. 2009). Subsequently, there is growing evidence to suggest that endothelial 
dysfunction could be regarded as an important prognostic factor preceding the manifestation of 
cardiovascular disease (Landmesser & Dexler 2005; Yoshida et al. 2006; Martin & Anderson 2009). 
Dietary factors can be important e.g. the Western type diet, with its high salt and high fat content 
plays a significant  role in the development of endothelial dysfunction whereas low sodium or low 
fat intake has benefitted endothelial function in animal and human studies (tables 1a,b - 2a,b). 
Numerous epidemiological and intervention studies have confirmed that dietary modification e.g. 
adhering to a Mediterranean diet, (typical main meal content: fish instead of red meat, whole-
wheat grains and products, low-fat dairy products, plenty of fruits and vegetables, almonds and a 
150 ml glass of red wine)  is associated with a lower incidence of coronary heart disease (Bibbins-
Domingo et al. 2010; Engelfriet et al. 2010; Davis et al. 2007; Lairon 2007).  In addition, caloric 
restriction but ensuring adequate nutrient intake also benefits cardiovascular health (Fontana & 
Klein 2007). Dietary modification may influence cardiovascular health via reduction of oxidative 
stress, decreased production of inflammatory cytokines, lowered coagulation abnormalities, 
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favourable effect on lipid profile and an improvement in endothelial function. However, the 
precise molecular mechanisms which dietary modulations  favors cardioprotection remain unclear 
(Davis et al. 2007). 
 18 
Table 1a. Studies conducted with isolated arterial rings examining high fat intake and  vascular dysfunction in experimental animals. 
Studies published after the year 2000 are provided in the list according to animal species. 
ED= endothelial dysfunction, GPX = glutathione peroxidase; HO = hemeoxygenase 
 
Animal model Duration Main Results Reference 
C57Bl/6 mice 12 weeks Increased vasoconstriction to phenylephrine, decreased eNOS (S1177) phosphorylation 
ED 
Symons et al. 2009 
 10 weeks Increased superoxide formation and NADPH-oxidase subunit p22 expression, ED Sumiyoshi et al. 
2008 
 17 weeks decreased eNOS dimer/monomer ratio; ED Yamamoto et al. 
2008 
 9 weeks decreased eNOS dimer/monomer ratio, increased nitrotyrosine staining; ED Molnar et al. 2005 
 30 weeks increased endothelium-derived contractile prostanoids, increased thromboxane receptor gene 
expression, increased thromboxane synthase expression, ED 
Traupe et al. 2002a 
Sprague-Dawley 
rats 
6 weeks decreased eNOS activity due to reduced eNOS phosphorylation, increased superoxide formation, ED Deng et al. 2010 
 14 weeks increased NOx, increased superoxide, increased nitrotyrosine, decreased eNOS phosphorylation, 
increased iNOS phosphorylation; increased NADPH-oxidase, decreased antioxidant capacity; ED 
Li et al. 2007 
 4 weeks increased vascular superoxide formation; ED Vismanad et al. 2006 
Wistar rats 8 weeks reduced Akt activation, decreased eNOS expression, decreased eNOS phosphorylation; ED Zecchin et al. 2007 
Fisher rats 28 weeks upregulation of NADPH oxidase and downregulation of SOD isoforms, GPX and HO-2 in the aorta; ED Roberts et al. 2006 
Pigs 12 weeks increased production of superoxide and augmented expression of nitrotyrosine and NADPH oxidase 
subunits, ED 
Galili et al. 2007 
 16 weeks decreased endothelium-dependent hyperpolarization and prostacyclin production, ED Woodman et al. 
2005 
 20 weeks increased endothelium-derived contractile prostanoids, decreased eNOS expression, ED Henderson et al. 
2004 
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Table 1b. Clinical studies on fat intake in children, adults and overweight adult published after the year 2000. 
  
 
The number of subjects Intervention Main outcome Reference 
90 subjects with 
abdominal obesity  
without cardiovascular 
disease or type 2 diabetes 
Participants were randomly assigned to the intervention or 
control group. Both groups were instructed to follow a 
Mediterranean-style diet for 2 months. Subjects in the 
intervention group additionally had to follow a specific relevant 
daily and weekly food plan with close supervision by a dietitian 
and provision of basic foods. 
The intervention group had improved endothelial 
function whereas no effect was found in the control 
group. Changes in lipids and CRP concentrations did 
not differ between the 2 groups. Diastolic blood 
pressure decreased in the intervention group 
markedly more compared with the control group. 
Rallidis et 
al. 2009 
40 overweight men and 
women 
Subjects with moderate hypertriacylglycerolemia were randomly 
assigned to consume hypocaloric diets restricted in carbohydrate  
or low fat diet. Fasting and postprandial vascular function was 
assessed by  measuring flow-mediated dilation of the brachial 
artery before and after ingestion of a high-fat meal  at baseline 
and after 12 weeks. 
a 12-week low-carbohydrate diet improved 
postprandial vascular function more than a low fat 
diet in individuals with atherogenic dyslipidemia. 
Volek et al. 
2009 
20 healthy men Three different diets; a Western diet enriched with saturated fat 
(SFA); a Mediterranean diet enriched  with monounsaturated fat 
(MUFA) or a low-fat diet enriched with  alpha-linoleic acid (ALA) 
MUFA-rich diet led to greater endothelium-dependent 
vasodilatory response, lower 4 h postprandial plasma 
soluble VCAM-1 levels and higher bioavailability of 
NOx than after the SFA and ALA low-fat diets. 
Fuentes  et 
al. 2008 
1062 randomized healthy 
7-month-old infants 
To compare endothelial function of brachial artery between low-
saturated-fat diet and control unrestricted diet groups after 10 
years in boys and girls. 
A low-saturated-fat diet introduced in infancy and 
maintained during the first decade of life is associated 
with enhanced endothelial function in boys. 
Raitakari et 
al. 2005 
26 young, healthy men 
and women aged 20-30 
years 
To investigate the acute effect of meals with different fat 
contents on  endothelial function. 
Low-fat meals did not attenuate endothelial function, 
in contrast with an ordinary Western meal, which 
transiently impaired endothelial function. 
Steer et al. 
2003 
 20 
 
Table 2a. Studies conducted with isolated arterial rings examining high-salt intake and vascular dysfunction in experimental animals. 
Studies published after the year 2000 are provided in the list according to animal species. ED = endothelial dysfunction 
 
Animal model Duration Main result Reference 
C57Bl/6 mice 24 weeks increased vascular superoxide production and decreased NO bioavailability; ED Ma et al. 2010 
 12 weeks increased alpha-adrenergic contractile responses; increased vascular type of collagen I 
and III. 
Yu et al. 2004 
C57Bl/6 mice 
overexpressing 
preproendothelin-
1 
4 weeks increased NADPH oxidase activity; ED Amiri et al. 2010 
Sprague-Dawley 
rats 
3 days increased mesenteric artery superoxide production, increased NADPH-oxidase and 
xanthine oxidase activity; impaired NO release, ED 
Zhu et al. 2007 
 3 days increased aortic superoxide production, ED Zhu et al. 2004 
 3 days decreased NO release in cerebral arteries, ED Sylvester et al. 
2002 
 6 weeks increased aortic vasoconstriction to noradrenaline; ED Ettarh et al. 2002 
Dahl salt-sensitive 
rats 
12 weeks increased aortic superoxide formation from endothelial cells and from eNOS; 
increased contractile response to ET-1, ED 
Zhou et al. 2010 
 8 weeks ED Hermann et al. 
2003 
 4 weeks ED Zhou et al. 2000 
Stroke-prone 
spontaneously 
hypertensive rats 
6 weeks ED, increased preproendothelin-1 mRNA levels in aortic tissue Krenek et al. 2001 
Goto-Kakizaki rats 8 weeks ED, impaired endothelium-dependent hyperpolarization Cheng et al. 2001 
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Table 2b. Clinical studies on salt intake  in normotensive, hypertensive and obese humans published after the year 2000. 
BP = blood pressure; PWV = pulse wave velocity; FMD = flow mediated dilatation; ADMA = asymmetric dimethyl arginine 
The number of subjects Intervention Main result Reference 
35 hypertensives To compare diets containing NaCl 0 g/d, 5 g/d or  
8 g/d for 4 week. 
Dietary salt loading produced significant increases 
in PWV and BP in hypertensive volunteers in  
proportion to sodium consumption. 
Todd et al. 2010 
29 overweight and obese 
normotensive men and women 
To compare diets containing NaCl 3 g/d  with   
 9 g/d  for 2 wk. 
Salt reduction improves endothelium-dependent 
vasodilation in normotensive overweight and  
obese subjects independently of the changes in 
measured resting clinic blood pressure. 
Dickinson et al. 
2009 
25 otherwise healthy adults aged 
48-73 years with high normal 
systolic BP or stage I systolic 
hypertension (130-159 mmHg) 
To compare self-reporting low NaCl < 6 g/d with  
high NaCl (6-12 g/d). 
Low sodium intake is associated with enhanced 
brachial artery FMD in human subjects with 
elevated systolic BP 
Jablonski et al. 
2009 
16 healthy normotensive male 
volunteers 
Randomized in a double-blind crossover fashion to 
5-day treatment periods with either placebo or salt 
tablets (12 g/d of NaCl) separated by a 2-week 
washout period. Throughout the study the 
volunteers were asked to maintain a low-salt diet. 
Salt loading impaired vascular endothelial 
function, left ventricular mechanical relaxation, 
and electric repolarization in young healthy 
normotensive individuals. 
Tzemos et al. 
2008 
15 normotensive postmenopausal 
women     (age 50-60 years), no 
estrogen 
To compare diets containing NaCl 4 g/d with 15 g/d  
for 7 days. 
High-salt intake increases BP and plasma levels of  
ADMA which are associated with impaired 
endothelial function. 
Scuteri et al. 2003 
29 patients with essential 
hypertension 
To compare diets containing sodium 3 g/d with  
20 g/d   for 1 week. 
Forearm resistance artery endothelial function is 
not influenced by salt loading. 
Higashi et al. 
2001 
26 salt-sensitive hypertensives and 
19 salt resistant but hypertensives. 
To compare diets containing NaCl 3 g/d with  
20 g/d. 
High salt intake decreased 24-hour urinary nitrate 
excretion and impaired endothelium-dependent 
vasodilatation in salt-sensitive patients. 
Bragulat et al. 
2001 
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2.5 MECHANISMS OF VASCULAR DYSFUNCTION 
 
Endothelial dysfunction is characterized by impaired endothelium-dependent vasodilatation in 
association with dysregulation of multiple cell signalling pathways involved in the normal 
regulatory roles of the endothelium (figure 3). According to accumulating evidence, diminished 
endothelium-derived NO bioavailability is considered to be the major mechanism underlying 
defective endothelium-dependent control of vascular homeostasis. Consequently, in conditions of 
diminished NO bioavailability, the endothelium becomes activated i.e. a condition in which 
arterial wall promotes thrombosis, inflammatory cell adhesion and prooxidant milieu. Therefore, 
any perturbation in   NO bioactivity predisposes the individual not only to altered vasomotor tone 
but also to  potential impairments in events controlling the development of atherosclerosis (figure 
3). Moreover, endothelial dysfunction is not completely equivalent to the inability of the 
endothelium to generate adequate amounts of bioactive NO but it is also linked to an imbalance 
between  other vasoactive endothelium-derived factors such as PGI2 and EDHF  and endothelium-
derived contracting agents (Feletou & Vanhoutte  2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Consequences of impaired endothelial cell function on vascular health (modified from 
Rubio & Morales-Segura 2004; Alessi & Juhan-Vague 2008; Chen & Stinnet 2008; Vanhoutte 2009; 
Wilson et al. 2009). ICAM = intercellular adhesion molecule; IL-6 = interleukin-6;  MCP = monocyte 
chemoattractant molecule; PAI = plasminogen activator inhibitor; VCAM = vascular cell adhesion 
molecule.  
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Vascular remodelling and smooth muscle cell
hypertrophy
-infiltration of monocytes into subendothelial space
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2.5.1. General properties and regulation of reactive oxygen species 
Cellular respiration and metabolism continuously generate forms of low levels of ROS including  
superoxide (O2-) which is a precursor for other more hazardous ROS, such as H2O2 and  hydroxyl-
radicals (OH-). Generally, ROS play an important role in monitoring oxygen tension and mediating 
signal transduction from membrane receptors in many different physiological processes. In 
addition, low concentrations of ROS exert VSMC relaxation in a wide range of vascular beds 
thereby controlling vascular tone. Under normal physiological conditions, small concentrations of 
O2- are effectively eliminated by the three isoforms of vascular superoxide dismutase (SOD). SOD 
converts O2- into H2O2 which is in turn decomposed into water, predominantly by catalase and 
glutathione peroxidase, critical endogenous and abundantly expressed antioxidant enzymes 
(Dröge 2002).  
 
2.5.2 Vascular oxidative stress 
Oxidative stress is determined as the state in which excess ROS overwhelm the endogenous 
antioxidant system. There is compelling evidence to suggest that cardiovascular risk factors 
including hypercholesterolemia, hypertension, diabetes and aging are associated with enhanced 
oxidative stress (Heistad 2006). In pathological conditions, the principal sources of vascular O2- are 
NADPH oxidase, XO, uncoupled eNOS, mitochondrial electron transport chain, lipoxygenases, 
cytochrome P450 monooxygenases and COXs.  These enzyme sources are vigorously activated 
and/or overexpressed, resulting in overproduction of free oxygen radicals. During prolonged 
periods of enhanced production of free oxygen radicals,  the antioxidative system may collapse 
becoming  downregulated,  thus leading to further impaired removal of ROS in the vascular wall 
(for review see Taniyama  & Griendling  2003; Heistad 2006). 
 
2.5.3 Effects of oxidative stress on vascular function 
Oxidative stress attenuates NO bioavailability by increasing the chemical degradation of NO. This 
proposal is based on results from bioassay studies showing that elevated levels of O2- suppress NO 
production and its bioactivity. In early bioassay studies, endothelial derived NO was shown to be 
inactivated by addition of pyrogallol, a generator of exogenous O2- whereas addition of SOD 
improved NO production (Ignarro et al. 1988). After these seminal findings, experimental evidence 
further demonstrated that in animal models of hypertension and hypercholesterolemia, NO 
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production was not compromised but rather increased although endothelium-dependent 
vasodilatation was impaired (Bouloumié et al. 1997; Kerr et al. 1999; d'Uscio et al. 2001). This led to 
the assumption that the increased degradation of endothelial derived NO by oxidative stress could 
account for vascular dysfunction due to impaired NO bioavailability (figure 4). In fact, when 
produced in close vicinity within a diameter of an endothelial cell, both NO and O2- rapidly 
undergo an interaction. (Rojas et al. 2006) This chemical event occurring at a three times higher 
rate outcompetes the normal reaction with SOD and O2-, leading ultimately to decreased NO 
bioactivity (Pacher et al. 2007). Elevated levels of O2- inactivate also GC, a selective target receptor 
for NO (Munzel et al. 2005).  
 
Moreover, elevated levels of ROS increase vascular tone also by inhibiting the other two  major 
endothelium-dependent vasodilators,  PGI2 and EDHF. The detrimental reaction between O2- and 
NO produces ONOO- which further inhibits GC, inactivates PGI2 synthase via tyrosine nitration 
and enhances oxidative stress by inhibiting SOD (Zou et al. 2004; Munzel et al. 2005). Additionally, 
high concentrations of O2-. decrease  the open probability of   K+ATP, KCa, and Kv  -channels thereby 
impairing the hyperpolarization induced by EDHF (see review for Gutterman et al. 2005). H2O2 
decreases the hyperpolarization of NO and subsequent electrotonic signaling by inhibiting the 
functionality of myoendothelial and VSMC gap junctions (Griffith et al. 2005). H2O2 also impairs 
P450 monooxygenase derived metabolites and inhibits their vasodilatation induced by 
hyperpolarization of the plasma membrane of VSMC (Larsen et al. 2008). In contrast, removal of 
OH- attenuates spontaneous tone and enhances NO bioavailability in SHR rats (Michel et al. 2007). 
The elevated levels of O2- promotes the production of contractile and proinflammatory prostanoids 
TXA2 and PGE2 in type II diabetic rats (Matsumoto et al. 2007). Taken together, a high output of 
endothelium derived ROS has major influences on vascular reactivity and tone, on the one hand 
through decreasing the bioavailability of endogenous vasodilators and on the other via an increase 
in the production of endothelium-derived contractile factors (figure 4; Stocker & Keaney 2004; 
Heistad 2006). 
 
 
 
 
 25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  Interactions of nitric oxide and superoxide in the regulation of endothelium-dependent 
vascular tone. (Modified from Vanhoutte  2001.) 
AA = arachidonic acid; eNOS = endothelial nitric oxide synthase; SOD = superoxide dismutase; O2- = 
superoxide anion; H2O2 = hydrogen peroxide; ONOO- = peroxynitrite; COX = cyclo-oxygenase; sGC = soluble 
guanylate cyclase; cGMP = cyclic guanosine monophosphate; OH- = hydroxyl radical anion; NADPDH-ox = 
nicotine adenine dinucleotide phosphate hydrogen oxidase; PGH 2 = prostaglandin H2; TP = receptor for 
thromboxane/other contractile prostanoids 
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2.5.4 Vascular damage caused by oxidative stress  
The most crucial consequence of the altered vascular redox state is the expression of 
proinflammatory genes that are regulated directly or indirectly by ROS (figure 5; Irani  2000). ROS 
can enhance the activation of redox sensitive transcription factors including nuclear factor kappa-B 
(NF-κB), the activator protein-1 (AP-1) and hypoxia inducible factor-1 (HIF-1) and  PPARs (Rojas 
et al. 2006). These signalling events result in altered gene expression such as monocyte chemotactic 
protein-1 (MCP-1), vascular cell adhesion molecule 1 (VCAM -1), intercellular adhesion molecule 1 
(ICAM-1), E- and P-selectins, IL-6, iNOS, COX-2 and reactive advanced end-glycation products 
(RAGE).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Long-term effects of vascular oxidative stress as a cause of atherosclerosis. (Modified 
from Förstermann 2006) AP-1 = activator protein-1; COX = cyclooxygenase; eNOS = endothelial 
nitrix oxide synthase; NF-kB = nuclear factor kappa B, ROS = reactive oxygen species;  SOD = 
superoxidedismutase;  = induces; --I = inhibits 
 
 
Cardiovascular risk factors
Genetic predisposition
Vascular oxidative stress
ROS producing enzymes:
Mitochondrial respiration chain
NADPH-oxidase
Xanthine-oxidase
Dysfunctional eNOS
Lipoxygenases
COXs
P450-monooxygenases
ROS detoxifying enzymes
SOD
Catalase
Glutathione peroxidase
Heme oxygenase
Thioredoxin
Paraoxonase
Activation of redox-sensitive
transcription factors: NF-kB, AP-1
Expression of proinflammatory
genes (chemokines, cytokines,
adhesion molecules)
ATHEROSCLEROSIS
 27 
2.6  ENZYME SOURCES OF THE OXIDATIVE STRESS IN THE VASCULAR WALL 
2.6.1  NADPH-oxidase 
NADPH oxidase, originally discovered in neutrophils, is the major  enzyme ROS source  
throughout  all layers of the arterial wall. All the classical neutrophil oxidase components are also 
expressed in endothelial cells: a membrane-associated low-potential cytochrome b558 composed of 
one p22phox and one gp91phox subunit and several cytosolic regulatory subunits (p47phox, p40phox, 
p67phox), and the small G proteins (Rac1 or Rac2). Homologs of the cytochrome subunit of 
phagocyte NADPH-oxidase are also called NOX oxidases and are divided into NOX1-NOX5. It is 
noteworthy, that NADPH-oxidase is the only source whose predominant function appears to be 
ROS production. It seems to be well suited for involvement in redox signalling. NADPH-oxidases 
has also a major potential to increase ROS formation by other enzymes. Finally, NADPH-oxidase 
activation is stimulated by various physiological and pathological conditions: substances such as 
G-protein coupled agonists Ang II and ET-1; growth factors; cytokines; hypercholesterolemia and 
hyperglycemia; mechanical shear and stretch; and hypoxia-reoxygenation. An acute increase in 
oxidase complex formation or a chronic increase in the expression and abundance of component 
subunits are believed  to cause overall  elevated ROS formation by NADPH-oxidase (Lasseque & 
Clembus 2003;  Ray & Shah 2005: Bedard & Krause 2007; Brandes & Schröder 2008).  
 
Aortas obtained from rats with renovascular hypertension display both impaired endothelium-
dependent and independent vasodilatation due to high levels of O2- from NADPH-oxidase 
(Heitzer et al. 1999). In human diabetic patients, increased expression of the levels of NADPH 
oxidase protein subunits (p22phox, p67phox, and p47phox) are associated with the augmented 
generation of vascular O2- and endothelial dysfunction (Guzik et al. 2002). Patients with coronary 
artery disease exhibit increased expression of NADPH oxidase subunit gp91-phox which is critical 
for endothelial O2- formation (Rueckschloss et al. 2002). In small coronary arteries of obese Zucker 
rats, NADPH-oxidase derived ROS formation accounts for impaired NO bioavailability and 
vasodilatation in response to insulin (Katakam et al. 2005). Augmented contractile and impaired 
endothelium-dependent vasodilator response are restored treatment with apocynin in mesenteric 
arteries from high-cholesterol -diet-fed mice (Matsumoto et al. 2006). In a setting of nitrate 
tolerance, this  inhibitor of NADPH-oxidase, i.e. apocynin, improves NO bioavailability via 
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restoring basal release of NO and increasing mRNA and protein levels of eNOS (Fukatsu et al. 
2007). 
 
2.6.2 Renin angiotensin- aldosterone system  
Hypercholesterolemia greatly augments both systemic and tissue renin angiotensin –aldosterone 
system (RAAS) by  increasing the levels of the components of  the conventional pathway for Ang II 
synthesis (Daugherty et al. 2004). Blood vessels obtained from hypercholesterolemic animals as 
well as platelets from hypercholesterolemic patients display increased expression of angiotensin II 
receptor subtype AT1 (Vergnani et al. 2000; Nickenig et al. 1999).  Additionally, ACE activity as 
well as local Ang II concentrations are increased in atherosclerotic plaques (Diet et al. 1996; Ohishi 
et al. 1997). Moreover, Ang II stimulates NADPH-oxidase activity in the mouse aortic wall,  
suggesting that activated RAAS could cause increased vascular free oxygen radical formation and 
thus endothelial dysfunction (Zemse et al. 2007). Ang II- induced hypertension is associated with 
endothelial dysfunction and  enhanced arterial production of O2-  which is ameliorated by 
endothelium removal or treatment with  diphenylenieiodinium  or apocynin,  inhibitors of 
NADPH-oxidase (Rajagopalan et al. 1996). Interestingly, monocyte adhesion to ECs, a critical step 
in the initiation of the atherosclerotic lesion, can be propagated by co-culturing renin-expressing 
macrophages  and this can be  prevented by aliskiren, a novel renin inhibitor (Lu et al. 2008b). 
 
2.6.3 Xanthine-oxidase 
XO is not detectable in ECs under physiological conditions whereas its expression due to  
enzymatic conversion from  xanthine dehydrogenase (XDH) is highly propagated under various 
pathological conditions such as hypoxia and the presence of proinflammatory cytokines. XO 
catalyzes reactions in which there is a  reduction of molecular oxygen yielding large  amounts of 
both O2- and H2O2. Therefore, XO is now regarded as a potential source of ROS in cardiovascular 
diseases (Berry & Hare 2004; Meneshian & Bulkley 2002). Although presice molecular mechanisms 
to explain the activation of vascular XO are not clear, it seems most likely that under pathological 
conditions such as hypercholesterolemia liver and possibly other tissues liberates XO into the 
circulation. In blood XO binds to the sulphate glyscosaminoglycans on the surface of ECs (White et 
al. 1996). Furthermore, ECs exposed to oscillatory shear stress but lacking NADPH-oxidase p47phox 
subunit are less prone to conversion of XDH to XO, thereby showing reduced O2- formation linked 
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with  lower activity and the reduced protein content of XO (McNally et al. 2003). This suggests in 
turn that NADPH-oxidase derived oxidant stress is a pivotal inducer of XO. 
 
XO-dependent overproduction of vascular O2- and subsequent endothelial dysfunction has been 
observed in  hypercholesterolemic experimental animals (Ohara et al. 1993; Tarpey et al. 1996; 
White et al. 1996); in microvessels obtained from SHR (Suzuki et al. 1998); in double-transgenic rats 
harboring human renin and human angiotensinogen genes (Mervaala et al. 2001); in 
atherosclerotic Apo E-deficient mice (Schröder et al. 2006); in aging rats  (Newaz et al. 2006); in 
cultures of cerebral ECs (Beetsch et al. 1998) and in streptozotocin induced-diabetes (Inkster et al. 
2007). Moreover, clinical studies support the importance of XO as a pivotal factor being 
contributing  to endothelial dysfunction and oxidative stress. Prevention of the activation of XO is 
linked with improved cardiovascular function in hypercholesterolemic patients (Cardillo et al. 
1997); in type 2 diabetic patients with mild hypertension (Butler et al. 2000);  in  patients with 
chronic heart failure (Farquharson  et al. 2002);  in heavy smokers  (Guthikonda et al. 2003) and in 
patients with coronary heart disease (Spiekermann et al. 2003).  
   
2.6.4. Mitochondrial respiratory chain 
Mitochondrial dysfunction is a common feature of most cardiovascular diseases (Madamanchi  & 
Runge  2007). Mitochondria generate constant amounts of superoxide as byproducts in normal 
physiological processes of ATP production and in oxygen mediated cell respiration via distinct 
respiratory complexes (Fridovich   1998). The actual amount of superoxide released by the 
mitochondria depends on the activity of manganese-containing superoxide dismutase (MnSOD) 
which is located in the mitochondrial matrix (Paul & Duttaroy 2003). Mitochondrial dysfunction as 
a result of MnSOD deficiency accelerates atherosclerosis in ApoE-/- mice (Ohashi et al. 2006). Ang II 
dysregulates mitochondrial membrane depolarization via activation of  mitochondrial K+- channels 
that in turn augment depolarization and   mitochondrial H2O2 production, ultimately disturbing 
mitochondrial respiration and uncoupling of oxidative phosphorylation (Doughan et al. 2008).   
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2.6.5 Uncoupled eNOS 
Under tightly regulated physiological conditions, eNOS catalyzes the appropriate  formation of 
vascular derived NO production while only small levels of oxygen derived free radicals are 
concomitantly released. Any disruption at the cellular delivery of these two factors disturbs NO 
generation leading to overwhelming  O2-, H2O2 and ONOO-  production. The transformation of 
eNOS from a protective enzyme to a contributor of oxidative stress is referred to as NOS 
uncoupling (Stuehr et al. 2001; Förstermann 2006). Other isoforms of  NO-synthases (iNOS, nNOS) 
are also capable of  generating  substantial amounts of  ROS but  their uncoupling in the 
pathogenesis in endothelial cell dysfunction remain unclear. Since the vasomotor tone in large 
conduit arteries is  principally regulated by eNOS, its uncoupling is thought to play a major role in 
the context of endothelial dysfunction (Andrew & Mayer 1999). Therefore, eNOS uncoupling can 
be regarded as a critical pathogenetic event, promoting the susceptibility of arteries to the 
development and progression of atherosclerotic vascular diseases (Munzel et al. 2005). Evidence 
for   uncoupled eNOS comes from   observations in endothelial cells exposed to native LDL 
cholesterol (Pritchard et al. 1995), in isolated human aortic endothelial cells in  hyperglycemic 
conditions  (Cosentino et al. 1997); in a rat model with genetic hypertension (Kerr et al. 1999); in a 
rat model with salt-sensitive hypertension (Zhou et al. 2003); in aortas of insulin resistant rats 
(Shinozaki et al. 2000);  in streptozotocin-induced diabetes mellitus (Wenzel et al. 2008) and in  
ApoE-/- mice (Laursen et al. 2001). Additionally, in human patients eNOS uncoupling has been 
demonstrated in diabetes (Thum et al. 2007); in congestive cardiac failure (Dixon et al. 2003) and in 
chronic smokers (Heitzer et al. 2000). Oxidative stress  is now considered to be one of the most 
important events resulting in uncoupling of eNOS (Xu et al. 2006; Heistad 2006).  
 
2.6.5.1 Deficiency of BH4 
Optimal cellular levels of BH4 are critical for calcium-dependent production of NO by eNOS 
(Channon 2004). Decreases in BH4 binding affinity due to decreases in cellular BH4 concentrations 
may alter enzymatic activity, leading to O2- generation from eNOS (Berka et al. 2004; Vasquez-
Vivar et al. 1998). In transgenic mice overexpressing endothelial GTP cyclohydrolase I (GCH), the  
rate limiting enzyme in BH4 synthesis, the eNOS activity is markedly increased as compared with 
wild-type littermates. This indicates that BH4 levels may limit enzymatic eNOS activity in vivo and  
even in the absence of a vascular disease state (Bendall et al. 2005). It has also been  proposed that 
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potentially beneficial sustained increases in eNOS expression and activity could lead to eNOS 
uncoupling and O2- production as a consequence of cellular deficiency of BH4 (Bevers et al. 2006).  
 
Streptozocin-induced diabetic mice exhibit endothelial-derived O2- production linked with 
decreased vascular levels of BH4 which become  completely restored  in GCH- transgenic  mice 
(Alp et al. 2003). Upregulation of local RAAS via enhanced AT1-receptor stimulation by Ang II is 
also linked to augmented NADPH-oxidase-dependent ROS  formation, resulting in the loss of the 
BH4 salvage enzyme,  dihydrofolate reductase and ultimately to a  deficiency in the  vascular 
content of BH4  in the ECs (Oak & Cai 2007).  The interaction of O2- and NO leads to ONOO- 
formation. ONOO- in turn stimulates eNOS derived O2- production being capable of  oxidizing  
efficiently the critical cofactor BH4 and to release Zn-ions from the  eNOS enzyme complex 
(Laursen et al. 2001; Landmesser et al. 2003; Alp et al. 2003). These pathological processes most 
likely can  impair eNOS catalytic activity (figure 6). ONOO- induced endothelial dysfunction is 
reversed by supplementation of BH4  which is the essential cofactor for endothelium-derived NO, 
suggesting that ONOO- impairs endothelium-dependent vasodilatation through decreasing the 
levels of bioactive BH4 (Hong et al. 2001). 
 
2.6.5.2 Deficiency of L-arginine 
A high intake of L-arginine improves dysfunctional endothelium-dependent vasodilatation in 
hypercholesterolemic animals and  in human patients as well as  in humans suffering from 
essential hypertension (Girerd et al. 1990; Lekakis et al. 2002). The precise  molecular mechanism of 
action still remains controversial. Generally, the intracellular concentration of L-arginine in cell 
systems are rather constant and approximately 1000-fold  higher than the Km for purified eNOS,  
suggesting that a defiency in  L-arginine  is a  highly unlikely cellular condition. However, 
significant amounts of arginase enzymes expressed both in liver and vascular tissues may 
potentially reduce the actual cellular  bioavailability of L-arginine. It is noteworthy, that 
endothelial dysfunction has been observed to be associated with increased vascular arginase 
activity (Durante et al. 2007). On the other hand, the beneficial effects of L-arginine 
supplementation may also be related to non-NO dependent effects such as hyperpolarization of 
endothelial cell membranes; stimulatory influences on insulin, glucacon and growth hormone; 
attenuation of ACE and decreased peroxidation of lipids and reduced formation of O2- liberation 
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(Siasos et al. 2007). In contrast to complete suppression of O2- by the adequate availability of BH4, it 
is considered that L-arginine only delays but does not prevent ROS formation via eNOS (Berka et 
al. 2004). It has  also been postulated  that the ROS formation linked with the  small increases in the  
rate  of eNOS expression can be corrected by L-arginine supplementation whereas higher rates of 
eNOS expression are more dependent on the levels of BH4 (Bevers et al. 2006). Other groups have 
speculated   that endothelial dysfunction caused by uncoupled eNOS derived oxidative stress can 
be ameliorated by L-arginine only under conditions when the endothelium is impaired or when 
iNOS has been induced (MacKenzie & Wassworth 2003). Furthermore, under oxidative stress, the 
formation of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of eNOS, is 
propagated in the ECs due to subsequent reduced activity of   dimethylarginine dimethylamine 
hydrolase (DDAH) (Pope et al. 2007). ADMA is a substrate analogue for L-arginine thereby 
competing for binding to eNOS. 
 
2.6.5.3 Alterations in eNOS expression 
Additionally, high levels of O2- are converted to H2O2 which not only changes the vascular level of  
eNOS expression by transcriptional and translational pathways but also stimulates the  vascular   
arginase enzyme which contributes to reducing L-arginine availability (Cai 2005; Thengchaisri 
2006). Regardless of the potential mechanism leading to low output of endothelial derived NO, 
eNOS expression is not typically decreased after exposure  to large amounts of ROS or after 
depletion of endogenous antioxidant enzymes in fact  rather increased eNOS expression is 
frequently encountered (Zhen et al. 2008). Augmented arterial eNOS expression has also been 
described in the literature: in  experimental disease models including chronic consumption of 
high-fat and high-sodium diet (Roberts et al. 2003); lead-induced hypertension (Vaziri & Ding 
2001) and in ApoE-/- mice (Laursen et al. 2001). Moreover, genetically modified overexpression of 
eNOS is associated with endothelial dysfunction and reduced VSMC responsiveness to exogenous 
NO. This is thought to be due to reduced GC activity and decrease in protein kinase G (PKG) 
protein levels (Yamashita et al. 2000). Genetic overexpression of eNOS also results in endothelial 
dysfunction and accelerated atherosclerosis in ApoE-/- (Ozaki et al. 2002).  Interestingly, eNOS 
deficient mice in turn display protection from atherosclerosis and a reduced tendency of ECs  to 
oxidize LDL cholesterol (Shi et al. 2002). In summary , the time period of eNOS overexpression and 
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the concomitant bioavailability of BH4 may determine whether altered eNOS expression has 
beneficial vascular effects (figure 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Potential mechanisms by which cardiovascular risks promote vascular oxidative stress, 
uncoupled eNOS and impaired  endothelial derived NO bioavailability (Modified from Pope et 
al. 2007). 
ADMA = asymmetric dimethyl arginine O2- = superoxide anion; SOD = superoxide dismutase; H2O2  = 
hydrogen peroxide; eNOS = endothelial  nitric oxide synthase; PRMT = protein arginine N-
methyltransferases; DDAH = dimethylarginine dimethylaminohydrolase; BH4 = tetrahydrobiopterin 
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3 Aims of the Study 
 
The objectives of the present study were as follows. 
 
1.  To investigate the effects of high salt intake on the development of endothelial dysfunction and 
atherosclerosis in ApoE-/- mice, a murine model of human atherosclerosis. 
 
2. To assess combined effects of high salt intake and high fat diet on endothelial function and 
progression of atherosclerosis in LDLR-/- mice, and to examine the role of increased oxidative stress 
in the pathogenesis of endothelial dysfunction. 
 
3.  To examine the molecular mechanisms of obesity-induced endothelial dysfunction and whether 
weight loss evoked by CR can reverse obesity-induced endothelial dysfunction in diet-induced 
obese mice, an experimental model of human obesity.  
 
4. To explore the role of PVAT in the pathogenesis of endothelial dysfunction in an experimental 
model of human obesity.  
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4 Materials and Methods 
4.1 EXPERIMENTAL ANIMALS 
Throughout this series of studies, the C57Bl/6 mouse was chosen as an experimental model for 
studying vascular effects of experimentally induced hypertension and obesity. In studies I-II 
investigating the vascular effects of a high salt diet, C57Bl/6 mice were used as genetic   
background for the mice carrying a targeted deletion for both ApoE-/-  and for LDLR-/- mice. In 
studies III-IV examining the vascular effects of high fat feeding, C57Bl/6 mice were used as a 
model for diet-induced obesity. Mice for studies I-II were commercially purchased from Jackson, 
West Grove, PA, USA. Mice for studies III-IV were commercially purchased from Harlan (Horst, 
The Netherlands). The study design of this thesis is shown in table 3. The mice were housed 5 
animals per cage in a standard experimental animal housing laboratory (automatically illuminated 
from 6.30 a.m. until 6.30 p.m.; temperature 22±1ºC). Every mouse had free access to tap water and 
laboratory food during the experiment.  
 
General characteristics of mice models 
C57Bl/6, wild-type mouse is the most widely used strain in experimental murine models of  
cardiovascular disease. This strain is highly susceptible to dietary modifications developing 
human-like obesity, type 2 diabetes and elevated arterial pressure in response to high fat and high 
sodium diets (Rebuffé-Scrive  et al. 1993, Mills et al. 1993; Surwit et al. 1995; Carlson & Wyss  2000; 
Gros et al. 2002). Additionally, wild-type mice are  also an adequate model for weight loss by CR 
which resembles the situation  in humans (Mahoney et al. 2006). Finally, C57Bl/6 mice are well-
established as a background for atherosclerotic mice models with genetic deficiency for ApoE-/- 
and LDLR-/- mice. Under normal circumstances,  wild-type mice are quite resistant to 
atherosclerosis owing to their high levels of antiatherosclerotic high density lipoprotein cholesterol 
(HDL) and low levels of proatherogenic LDL and very low density lipoprotein cholesterol (VLDL) 
(Temel & Rudel 2007). Therefore, genetic manipulations are required to establish atherosclerosis in 
these mice. One of the most frequently used murine model for atherosclerosis has been the ApoE-/-  
mouse . ApoE is synthetized in the liver and in macrophages serving as a ligand for the cell surface 
lipoprotein receptors such as the LDL-receptor. As a constituent of plasma lipoproteins, apoE 
promotes the uptake of atherogenic particles from the circulation.  Homogenous deletion of the 
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apoE coding gene leads to increased levels of chylomicrons, VLDL and LDL cholesterol. ApoE-/- 
mice fed regular chow-diet develop spontaneously atherosclerosis which can be drastically 
accelerated by high fat feeding in LDLR-/- mice (Plump & Breslow 1995). The atherosclerotic lesions 
of both ApoE-/- and LDLR-/- mice are human-like, developing over time from initial fatty streaks to 
complex lesions throughout the aortic tree (Plump & Breslow 1995). 
 
4.2 DIETARY INTERVENTIONS 
 
Caloric intake from carbohydrate, fat and protein obtained from study diets are shown in table 4. 
Commercially available regular laboratory mouse chow served as the control diet (Harlan Teklad, 
WI, USA; NaCl content 0.7%-0.8% wt/wt) in studies I-II. In study I, the high salt was mixed with 
control diet in order to achieve a final concentration of 7% as sodium chloride (NaCl). In study II, 
high fat diet was produced by adding NaCl free butter (18% wt/wt; Valio, Helsinki, Finland) and 
cholesterol (0.5% wt/wt; Sigma-Aldrich Corp.St.Louis, MO, USA) to the control diet.  The 
combined diet consisting of both high fat and high sodium was prepared by mixing the high salt 
with the high-fat diet. In study III, a commercially available diet was used as the  high-fat diet  
(D05031101M, Research Diets Inc., New Brunswick, NJ, USA) and  a standard laboratory animal 
diet was used as control diet (Teklad Global 2018S, Harlan Tekland, Oxon, England). In study III, 
CR was established by calculating the average daily consumption of rodent high-fat diet and after 
that by reducing the amount of high-fat diet by 30% from ad libitum intake. In study IV, a 
commercially available diet was used as the high-fat diet (D12492, Research Diets Inc., New 
Brundswick, NJ, USA) and a regular rodent diet served as the control diet (FG 811004, SDS diets, 
UK).  
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Table 3. Experimental animals and experimental design of the studies 
ApoE-/- = apolipoprotein E-deficient; eNOS = endothelial nitric oxide synthase; LDLR-/- = low 
density lipoprotein receptor deficient; NaCl = sodium chloride; oxLDL = oxidized low density 
lipoprotein; SBP = systolic blood pressure 
 
 
 
Study 
number 
Strain and 
gender 
Animal age 
at the 
beginning 
Experimental  
group and  number 
of animals in each 
group 
Duration 
of the 
study 
Main measurements 
 
I 
 
ApoE-/- mice 
C57Bl/6 
mice 
Male 
 
10-12 weeks 
 
ApoE-/- mice  +high-
NaCl (n=10) 
C57Bl/6 mice + high- 
NaCl (n=10) 
 
ApoE-/- mice (n=10)  
C57Bl/6 mice (n=10) 
   
 
12 weeks 
 
SBP, cardiac 
hypertrophy, endothelial 
function in the thoracic 
aorta, 
vascular superoxide 
formation,  
albuminuria 
 serum cholesterol, 
24-h-urine volume, 
urinary NOx 
 
II 
 
LDLR-/-  mice 
C57Bl/6 
mice 
Male 
 
10-12 weeks 
 
LDLR-/-  mice+ high-
fat 
 + high- NaCl (n=10) 
C57Bl/6 mice  
+ high fat + high- 
NaCl (n=10) 
LDLR-/-  mice + high-
fat (n=10) 
C57Bl/6 mice + high-
fat (n=10) 
LDLR-/-  mice + chow 
(n=10) 
C57Bl/6 mice + chow 
(n=10) 
 
12 weeks 
 
SBP, cardiac 
hypertrophy, endothelial 
function in the thoracic 
aorta, 
vascular superoxide 
formation,  
enzyme sources of 
vascular ROS, 
 serum cholesterol 
 
III 
 
C57Bl/6 
mice 
Male 
 
5-6 weeks 
 
C57Bl/6 mice + 
 high- fat (n=20) 
C57Bl/6 mice +  
normal fat (n=20) 
C57Bl/6 +high-fat + 
caloric restriction 
(n=10) 
 
21 weeks; 
caloric 
restriction 
7 weeks 
after 14 
weeks of 
weight 
gain  
 
total fat mass, fat 
percentage, fat 
distribution, endothelial 
function in the thoracic 
aorta, vascular 
superoxide formation, 
enzyme sources of 
vascular ROS, 
eNOS protein expression, 
serum oxLDL cholesterol, 
 
 
IV 
 
C57Bl/6 
mice 
Male 
 
5-6 weeks 
 
C57Bl/6 mice +  
high- fat (n=15) 
C57Bl/6 mice + 
normal- fat (n=15) 
 
 
32 weeks 
 
oral blood glucose test, 
total fat mass, fat 
percentage,area of 
perivascular fat mass; 
area of perivascular 
adipocyte; vascular 
function in the abdominal 
aorta;  superoxide and 
hydrogen peroxide 
formation in perivascular 
fat 
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Table 4. The  energy intake of study diets from macronutrients in this thesis. 
Study number Diet Calories from 
Carbohydrates 
(%) 
Calories 
from Fat 
(%) 
Calories from 
Protein (%) 
I, II Control, normal fat 69 12 19 
III Control, normal fat 60 17 23 
IV Control, normal fat 75 7.5 17.5 
     
II High-fat/high 
cholesterol 
47 40 13 
III High-fat 21 61 18 
IV High-fat 20 60 20 
 
 
4.3 MEASUREMENTS OF BLOOD PRESSURE AND HEART RATE 
 
Systolic blood pressure and heart rate of the pretrained mice were examined with a tail-cuff 
analyzer (Studies I-II) (Apollo-2AB, Blood Pressure Analyzer, Model 179-2AB, IITC Life Science, 
Woodland Hills, CA, USA). The mice were allowed to adapt to restrainers and the blood pressure 
measurement technique  for 10 days. Before the measurement, each mouse was warmed at 33-34ºC 
for 10 minutes to obtain  detectable pulsations from the  tail artery. The mean systolic blood 
pressure was calculated from 5-10 successful recordings. The heart rate was obtained during blood 
pressure measurement. Blood pressure measurements were commonly carried out at 2 p.m. The 
circadian rhythm of the mice was attempted to be maintained as normal. 
 
4.4 METABOLIC STUDIES 
 
The mice were housed invidually in metabolic cages in which they had free access to tap water and 
food. Food intake and consumption of water were recorded and urine was collected over 24-h 
periods. Urine volumes were measured (during the last week of Study I-II) and samples stored at -
80 ºC until the biochemical determinations were performed. The body weight was monitored once 
a week and the consumption of feed was checked daily using a standard laboratory table scale 
(Ohaus Scout™ Pro, SP4001, Nänikon, Switzerland). The amount of body fat was assessed by dual-
energy x-ray absorptiometry (DEXA, Lunar PIXImus, GE Healthcare, Chalfont St. Giles, UK) at the 
end of studies III-IV.  Prior to sacrifice, mice were weighed and glucose (2 mg/g body weight) was 
administered via an oral gavage.  Blood samples were drawn from the tail vein at 0, 15, 30, 60 and 
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90 minutes after oral glucose expose (oral glucose tolerance test, OGTT). Blood glucose (mmol/l) 
was analyzed by a glucometer (Super Glucocard™ II, GT-1630, Arkray Factory Inc., Shiga, Japan). 
 
4.5 COLLECTION OF BLOOD AND TISSUE SAMPLES 
 
At the end of the experiment, the mice were anesthetized with CO2/O2 (70%/30%) (AGA, 
Riihimäki, Finland). Blood samples were taken from the orbital plexus (in studies I-II) or after 
decapitation (in studies III-IV) into chilled tubes. The collected blood was centrifuged at +4 ºC for 
15 minutes then plasma and serum were stored at -80 ºC. The heart and kidneys were excised and 
removed, washed with ice-cold saline, blotted dry and weighed. The ratio of the heart weight to 
body weight was calculated as an index of cardiac hypertrophy. In separate studies for the 
examination of aortic atherosclerosis, heart with ascending aorta were snap frozen in liquid 
nitrogen and these samples were then stored at -80 ºC until assayed. The fat pads (subcutaneus, 
epididymal, retroperitoneal) were dissected and weighed. 
 
4.6 ASSESSMENT OF THE VASCULAR MORPHOLOGY 
The extent of atherosclerosis  
In studies I-II, the cross-sectional analysis of the extent of atherosclerosis was conducted from the 
aortic sinus along the ascending aorta up to 5 mm. The aortic samples were sectioned on a Leica 
cryostat (10µm). Cross-sectional serial sections were prepared and stained with hematoxylin and 
eosin to evaluate the atherosclerotic lesion area. Hematoxylin has a deep blue-purple color and 
stains nucleic acids in a complex, incompletely understood, reaction. Eosin is pink and stains 
proteins nonspecifically. In a typical tissue, nuclei are stained blue, whereas the cytoplasm and 
extracellular matrix have varying degrees of pink staining. Therefore, typical atherosclerotic fatty 
lesions are stained light-blue which are easily distinguishable  from  other tissue. The aortic lesions 
were quantified as percent lesion area per total area of the cross-sectional aorta. The percentage of 
area covered with fatty lesions was examined by light microscopy and analysed with Leica 
imaging software.  
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The extent of perivascular adipose tissue 
In Study IV, samples of abdominal aorta with intact PVAT from lean and obese mice were fixed in 
10% formalin and embedded in paraffin. Six-micron thick cross-sections of the aortas were stained 
with hematoxylin and eosin. Under light microscopy, morphology of aortic wall dimensions, the 
size of PVAT and the corresponding adipocytes were measured using Leica Qwin Standard- 
software (Leica Microsystems Imaging Solutions Ltd Cambridge, UK). 
4.7  WESTERN BLOT 
In Study III, pooled aortic samples (3-4 vessels) were electrophoretically separated by 8 % SDS-
PAGE (40 μg total protein per lane). Proteins were transferred to a PVDF membrane (Immobilon-
P®, Millipore, Bedford, MA, USA) and blocked in 0.05% non-fat milk-TBS - 0.01% Tween-20® 
buffer. The membranes were probed with the following dilutions of primary antibodies;  anti-
endothelial nitric oxide synthase (eNOS), 1:1000 (#SC654, Santa Cruz, CA,USA),  anti-
phosphorylated-eNOS (p-eNOS), 1:1000 (#SC12972R; Santa Cruz, CA, USA). Horseradish 
peroxidase-conjugated anti-rabbit secondary antibody (Chemicon, Temecula, CA, USA) was 
subjected to enhanced chemiluminescence solution (ECL plus, Amersham Biosciences, 
Buckinghamshire, UK) and exposed to x-ray film (Hyperfilm-ECL, Amersham). The alpha-tubulin 
expression was used as an internal standard for protein expression. The relative expressions of 
eNOS and p-eNOS were calculated by comparing with alpha-tubulin expression in each sample 
obtained from the x-ray film by densitometry (Synoptics, Cambridge, UK).  
  
4.8 REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION 
 
In Study IV, total RNA was isolated from fat tissue using Trizol (Invitrogen, Carlsbad, California, 
USA) and treated with DNAse 1 (deoxyribonuclease 1, Sigma Chemical, St Louis, MO, USA). 
Reverse transcription of mRNA was made by using ImProm-II Reverse Transcription System 
(Promega, Madison, Wisconsin, USA). qRT-PCR was performed according to manufactor’s 
instructions with LightCycler carousel based system (Roche Diagnostics). Results were normalized 
with 18S. 
The following primers were used (3´5´):  
MCP-1 forward CGGAACCAAATGAGATCAG, reverse TCACAGTCCGAGTCAC 
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Leptin forward AGACCGGGAAAGAGTG, reverse GCCATAGTGCAAGGTT 
Adiponectin forward GTATCGCTCAGCGTTC, reverse GTCGTTGACGTTATCTGC 
Ncf2  forward  CTGGCTGAGGCCATCAGACT, reverse AGGCCACTGCAGAGTGCTTG 
18S forward ACATCCAAGGAAGGCAGCAG, reverse TTTTCGTCACTACCTCCCCG 
(MCP-1 = monocyte chemoattractant protein-1; Ncf2 = neutrophil cytosolic factor 2) 
 
4.9 ARTERIAL RESPONSES 
 
Aortic relaxation responses were analyzed from thoracic aortic samples (in Studies I, II, III) and 
from abdominal aortic samples (Study IV). Briefly, connective tissue and adherent fat were 
removed in studies I-III, while in study IV also PVAT intact aortic rings were used. Blood vessel 
rings were made 2-3 mm wide and they were connected to an isometric force transducer (EMKA 
technologies, France 2000), suspended in an organ chamber filled with Krebs-solution of the 
following composition (mmol/l): NaCl 119.0, NaHCO3 25.0, glucose 11.1, CaCl2 1.6, KCl 4.7, 
KH2PO4 1.2, MgSO4 1.2 (37º C, pH 7.4) and aerated with 95% O2/5% CO2. Isometric tension was 
recorded continuously. After a 60-minute equilibration period, the rings were gradually stretched 
to the optimal point of their length-tension curve determined  as 0.7 g. This amount of active stress 
was about 0.3-0.4 g.  Then aortic rings were first challenged to high dose of KCl 60 mmol/L and 
this was repeated at least 3 times until a sustained contraction was achieved in each ring. Organ 
chambers experiments were carried out using mouse aortic rings preconstricted with NA or with 
Phe 1-10 µmol/l. Endothelium-dependent relaxation to Ach was recorded before and after 
preincubation with the superoxide scavenger 4,5-dihydroxy-1,3-benzenedisulfonic acid, Tiron (1 
mmol/l; 30`) in studies I-IV;  catalase in study II (1200 IU/ml, 30`) or polyethylene glycol catalase 
(PEG-catalase, 30`)  in study IV (150 IU/ml, 30`), aminotriazole in study II (50 mmol/l, 30`), 
carboxy-2-phenyl-4,4,5,5-tetra-methyl-imidazoline-1-oxyl-3-oxide (Carb-PTIO, 10-4 mol/l, 30`) in 
study IV , in study II diethyl-dithiocarbamate (DETC, 10-3 mol/l, 30`);  l-arginine in study III (10-3 
mol/l, 30`), l-norvaline in study III (10-3 mol/l, 30`), sepiapterin in study III (10-3 mol/l, 30`). 
Endothelium-independent relaxations were studied in response to sodium nitroprusside in 
studies I-IV (SNP).  Curves were produced and values were calculated by Graph Pad Prism 
version 4.02 software program.  
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4.10 MEASUREMENT OF VASCULAR REACTIVE OXYGEN SPECIES PRODUCTION 
 
In studies I-III,  aortic rings (4 mm in width) were equilibrated in Krebs solution (pH 7.4, 37ºC) 
aerated with oxygen (95%/5%; O2/CO2) for 30 minutes and then transferred into vials filled with 
Krebs enriched with lucigenin (5 µmol/l). The aortic rings were incubated in 96-wells-plate for 30 
minutes in the dark at 37ºC. Thereafter, the amount of superoxide was calculated from the 
chemiluminescence measurements (Liquid Scintillation Counter, 1450 MicroBeta, Wallac, Boston, 
USA). After the measurements, the aortic samples were dried and weighed and the results were 
reported as counts/mg/min. The specificity of lucigenin to monitor  aortic O2- generation was 
confirmed by preincubation of aortic rings with 10mmol/l Tiron that resulted in a 90% reduction in 
O2- measurement (data not shown). Tiron is a cell-permeant, nonenzymatic scavenger of 
superoxide anion, which was added to quench all superoxide dependent chemiluminescence. 
Pretreatments with apocynin (an inhibitor of NADPH-oxidase), L-NAME (an inhibitor of eNOS) 
and oxypurinol (an inhibitor of xanthine oxidase) were used to test enzyme sources for superoxide 
anions in studies II-IV Additionally, in study IV isolated samples of perivascular fat were 
investigated using luminol (250µmol/l) enhanced chemiluminesce technique. This method 
basically corresponds to lucigenin bioassay but also makes it possible to evaluate ROS  other than 
superoxide depending on the pharmacological scavenger used. Since it is highly cell-permeable, 
PEG-catalase 150 IU/ml was used to quench all of the  H2O2  formation. 
4.11 BIOCHEMICAL DETERMINATIONS  
In studies I-II, albuminuria was measured by commercially available ELISA kit with mouse 
albumin used as the standard (CellTrend GmbH, Germany). The urinary nitrate + nitrite (NOx) 
concentration was assessed with a commercially available NOx colorimetric assay kit (Cayman 
Chemical Company, Ann Arbor, MI, USA). Serum lipids were analyzed in an  accredited 
laboratory (Helsinki University Hospital Laboratory, Finland; Hitachi 912 Automatic Analyzer, 
Hitachi, Tokyo, Japan). Serum total cholesterol concentration was determined with an enzymatic 
method (Boehringer Mannheim CHOD-PAP-method), serum HDL cholesterol with an enzymatic 
direct method (Boehringer Mannheim HDL-Chol Plus) and serum triglycerides with an enzymatic 
method (Boehringer Mannheim CHOD-PAP-method). Blood glucose (mmol/l) was analyzed with  
a glucometer (Super Glucocard™ II, GT-1630, Arkray Factory Inc., Shiga, Japan). In study III, the 
amount of oxLDL cholesterol was measured by determining the level of baseline LDL diene 
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conjugation (Ahotupa et al. 1998). In brief, serum LDL cholesterol was isolated by precipitation 
with buffered heparin. Lipids were extracted from the samples and the amount of peroxidized 
lipids in the samples was determined by measuring the  conjugated diene double bonds analyzed 
spectrophotometrically at 234 nm.  
 
4.12 COMPOUNDS 
Ach, aminotriazole, apocynin, Carb-PTIO, catalase, DETC,  L-arginine, L-norvaline, L-NAME,  NA, 
oxypurinol, PEG-catalase, sepiapterin, SNP, Phe, tiron and chemical components of the Krebs-
solution: NaCl, NaHCO3, glucose, KCl, CaCl2, MgSO4, KH2PO4 were obtained from Sigma 
Chemical Company (USA). All concentrations, except catalase used in organ chamber experiments, 
are expressed as final molar (mol/l) concentration in the bath solutions.  
 
4.13 STATISTICAL ANALYSIS 
Data are presented as means ± standard error of means. Statistically significant differences 
between  mean values were tested by one way analysis of variance (ANOVA). ANOVA for 
repeated measurements was applied for data consisting of repeated observations at successive 
time points. The difference between groups was considered significant when p<0.05. The data 
were analysed using GraphPad Prism, version 4.02 (GraphPad Software, Inc., San Diego, CA, 
USA). 
4.14 ETHICS  
These studies were approved by the Animal Experimentation Committee of the University of 
Helsinki, Finland. 
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5 Results 
5.1 BODY WEIGHT 
In study I, consumption of a high salt diet did not change body weights in ApoE-/-   or in C57Bl/6 
mice (table 5).   In study II, the high fat/high cholesterol diet increased body weight in C57Bl/6 
mice but not in LDLR-/- mice (p<0.05; table 5).  Combined intake of high fat/high cholesterol diet 
and high salt diet did not alter body weights in  LDLR-/- or in C57Bl/6 mice. In study III, the high 
fat diet  increased body weight gain than the normal fat diet in  C57Bl/6  mice after 14 weeks of 
consumption (p<0.001) After 7 weeks of  CR, a  significant decrease in the  body weights of the 
obese mice was noted   though it was still  higher than normal fat fed lean mice (p<0.01; table 6). In 
study IV, feeding high fat diet for 32 weeks increased body weight in C57Bl/6 mice compared to 
normal fat feeding (p<0.001; table 6). 
Total fat mass, the extent of fat pads and body fat percentage 
In Study III, obese C57Bl/6 mice displayed markedly increased epididymal (p<0.01),  
subcutaneous (p<0.05) and retroperitoneal adipose tissue (p<0.01) (table 6).  CR attenuated these 
fat pads (p<0.001). Body fat percentage was markedly higher  in obese mice than in lean mice 
(p<0.001) whereas CR markedly decreased body fat percentage (p<0.01). In Study IV obese C57Bl/6 
mice mice had markedly increased  total fat mass and fat percentage relative to lean C57Bl/6 mice 
(p<0.001; table 6). 
5.2 SYSTOLIC BLOOD PRESSURE, CARDIAC HYPERTROPHY AND HEART RATE 
In Study I, consumption of a high salt diet markedly enhanced systolic blood pressure in both 
mice strains but this was more pronounced in the ApoE-/- mice (p<0.05; table 5).  When consuming 
a normal salt diet, cardiac hypertrophy was already markedly increased  in ApoE-/- mice compared 
to C57Bl/6 mice. The high salt diet increased cardiac hypertrophy in both mice strains, but more so 
in the ApoE-/- mice (p<0.05). In Study II,  combined high fat/ high cholesterol diet and high salt diet 
elevated both systolic blood pressure and caused  cardiac hypertrophy in both mice strains but 
more markedly in the LDLR-/- mice (p<0.05; table 5). In Studies I and II, none of the treatments or 
mouse strains influenced the heart rate of the mice. 
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5.3  RENAL FUNCTION 
Urine volumes, kidney hypertrophy, 24-h-albuminuria and NO metabolites 
In study I, the high salt diet  increased 24-h-urine volumes (p<0.01), causing albuminuria (p<0.01) 
and kidney hypertrophy (p<0.01) in both mice strains,  though the effect was more pronounced in  
ApoE-/-  mice (table 5). None of the treatments or mouse strains influenced  urinary NO metabolite 
excretion.  In Study II,  combined intake of a high fat/  high cholesterol and high salt diet  elevated 
urine volumes (p<0.01), induced kidney hypertrophy (p<0.01) and  augmented 24-albuminuria 
(p<0.01)  in both mice groups,  more  so in   LDLR-/- mice (p<0.01). Urinary excretion of NOx 
metabolites was significantly increased by the combined intake of high fat/high cholesterol and 
high salt diet in both mice groups but markedly more in C57Bl/6 mice (p<0.01) (table 5). 
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Table 5. Main findings in the studies I-II investigating the effects of dietary high salt alone or in combination with high-fat diet. 
Comparisons have been done according to study design and results in original publications. 
Study Strain Diet Body 
weight 
SBP Atherosclerosis Cardiac 
hypertrophy 
Albuminuria NOX Urinary 
volumes 
Total 
cholesterol 
I C57Bl/6 Chow - - - - - - - - 
I ApoE-/- Chow ↓ a ↑ a ↑ a ↑ a ↑ a ↔ ↔ ↑ a 
I C57Bl/6 High-NaCl ↔ ↑ a ↔ ↑ a ↑ a ↔ ↑ a ↔ 
I ApoE-/- High-NaCl ↔ ↑ b ↑ b ↑ b ↑ b ↔ ↑ b ↔ 
II C57Bl/6 Chow - - - - - - - - 
II LDLR-/- Chow ↓ a ↔ ↔ ↔ ↔ un ↔. ↔ un ↑a 
II C57Bl/6 High-Fat ↑ a ↔ ↔ ↔ ↔un ↔ ↔ un ↑a 
II LDLR-/- High-Fat ↔ ↔ ↑c ↔ ↔ un ↔ ↔ un ↑c 
II C57Bl/6 High-Fat + 
High-NaCl 
↔ ↔ ↔ ↑ d ↑ d ↑und ↑ un d ↔ 
II LDLR-/- High-Fat + 
High-NaCl 
↔ ↑ e ↑ e ↑ e ↑ e ↓ un e ↑ un e ↔ 
Data are expressed as means ± SEM,; ApoE-/- = apolipoprotein E-deficient; LDLR-/- = low density lipoprotein receptor-deficient; n.d. = not determined; un = unpublished 
data; - = control ↔ = unchanged; ↑ = increased; ↓= decreased  
a   p<0.05 vs. C57Bl/6 mice on chow; b  p<0.05 vs. ApoE-/- mice on chow; c   p<0.05 vs. LDLR-/- mice on chow; d p<0.05 vs. C57Bl/6 mice on high-fat diet; e p<0.05 vs. LDLR-/- 
mice on high-fat diet 
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Table 6. Main findings in the studies III-IV investigating diet-induced obesity in this thesis. Comparisons have been done 
according to study design and results in original publications 
 
a p<0.05 vs. C57Bl/6 mice on normal-fat  ; b p<0.05 vs. C57Bl/6 mice on high-fat diet ; n.d. = not determined; - = control ;↔ = unchanged; ↑ = increased and 
statistically significant; ↓= decreased and statistically significant 
 
Study Strain Diet Body 
weight 
Blood 
glucose 
Fat percentage Visceral fat Subcutaneous fat oxLDL 
cholesterol 
III C57Bl/6 Normal-fat - - - - - - 
III C57Bl/6 High fat ↑ a ↑ a ↑ a ↑ a ↑ a ↑ a 
III C57Bl/6 High-fat + 
CR 
↓a,↑b ↓a,↔b ↓a,↔b ↓a,↓b ↓a,↑b ↔a,↓b 
IV C57Bl/6 Normal-fat - - - - - n.d. 
IV C57Bl/6 High-fat ↑ ↑ ↑ ↑ ↑ n.d 
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5.4 BIOCHEMICAL PARAMETERS 
Total cholesterol, triglycerides and HDL-cholesterol  
In Study I, total cholesterol, high density lipoprotein cholesterol and triglycerides similarly 
developed during high salt  and normal salt diet in both  C57Bl/6 mice and ApoE-/- mice (table 5). 
ApoE-/- mice on the normal salt diet had markedly increased levels of  total cholesterol  and HDL 
cholesterol but similar levels of triglycerides as the C57Bl/6 mice.  In Study II, high fat/ high 
cholesterol diet markedly increased levels of total cholesterol, triglycerides and HDL-cholesterol in 
both  C57Bl/6 mice and in LDLR-/- mice but more markedly in LDLR-/- mice (table 5).  The 
combined intake of high  fat/ high cholesterol and high sodium diet evoked similar levels of  total 
cholesterol, triglycerides and HDL-cholesterol compared with high fat/high cholesterol diet in both 
mice strains.  
Serum levels of oxidized low density lipoprotein 
In Study III, feeding high fat diet for 21 weeks markedly increased  levels of oxLDL in C57Bl/6 
mice as compared with normal fat feeding (table 6). CR significantly reduced the levels of oxLDL 
in C57Bl/6 mice fed the high fat diet.  
Blood glucose 
In Study III, high fat diet markedly increased blood glucose levels in  C57Bl/6 mice as compared 
with a normal fat diet after 21 weeks of treatment (table 6). CR markedly decreased the extent of 
hyperglycemia in obese C57Bl/6 mice. In Study IV, mice fed the high fat diet for  32 weeks showed  
markedly impaired oral glucose tolerance compared to the  normal fat fed mice.  
5.5 TISSUE MORPHOLOGY 
The extent of atherosclerotic lesions 
In Study I, C57Bl/6 mice did not demonstrate atherosclerosis during normal or high sodium diets. 
High sodium diet increased atherosclerotic lesion area in ApoE-/- mice compared with ApoE-/- mice 
on normal sodium diet (table 5). In Study II, high fat feeding induced atherosclerosis in LDLR-/- 
mice as compared with normal fat. Combined intake of both high fat/ high cholesterol and high 
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sodium diet further significantly increased atherosclerotic lesion area in proximal aortas of LDLR-/- 
mice (table 5). 
The extent of periadventitial adipose tissue 
In Study IV, feeding the high fat diet for 32 weeks markedly increased both the areas of PVAT and 
the amounts of corresponding adipocyte as compared with a normal fat diet.  
5.6 AORTIC RESPONSES EX VIVO 
In study I, the high salt diet markedly increased contraction to NA in C57Bl/6 mice. In ApoE-/- and   
LDLR-/- mice, the contractions to NA were comparable regardless of the amount of dietary salt. The 
high salt diet impaired the endothelium-dependent vascular relaxation in response to Ach in 
C57Bl/6 mice. In ApoE-/- mice receiving normal sodium diet, endothelium-mediated vasorelaxation 
was already markedly impaired but the  high sodium diet did not further impair relaxation 
responses to Ach. Preincubation with Tiron  markedly improved endothelium-dependent 
vasodilatation in both C57Bl/6 and ApoE-/- mice. Endothelium-independent dilator responses to 
SNP were similar in both mice groups regardless of dietary salt (table 7). In study II, contractions 
to NA were comparable between C57Bl/6 and LDLR-/- mice on normal fat diet. The high fat /high 
cholesterol or its combination with high salt did not alter contractile responses in either mice 
strains. LDLR-/- mice on normal fat had impaired endothelium-dependent vasodilatation compared 
to C57Bl/6 mice. Consumption of the high fat/high cholesterol diet impaired endothelium-
dependent relaxation in  C57Bl/6 mice while in LDLR-/- mice the already blunted vasodilatation 
was not further impaired.  Combined intake of high fat/high cholesterol and high salt diet did not 
deteriorate further endothelium-dependent relaxation in C57Bl/6 mice. Combined intake of high 
fat /high cholesterol and high salt diet markedly impaired endothelium-dependent vasodilatation 
in LDLR-/- mice. Preincubation with Tiron markedly improved endothelium-dependent 
vasodilatation in both C57Bl/6 and LDLR-/- mice receiving  combined  high cholesterol/high  fat 
and  high salt diet. Preincubation with catalase inhibited endothelium-dependent relaxation in 
C57Bl/6 mice but not in LDLR-/- mice on the combined high fat/high  cholesterol and high salt diet. 
Preincubation with aminotriazole did not influence endothelium-dependent vasodilatation in 
either strain. DETC preincubation impaired endothelium-dependent vasodilatation in LDLR-/- mice 
fed high fat/high cholesterol diet to a similar degree as in the corresponding mice fed the  
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combined high fat/high cholesterol and high salt diet. Endothelium-independent relaxation 
responses to SNP were similarly developed in each mice strains and dietary groups (table 7). In 
Study III, the contractile responses to NA were comparable in normal and high fat fed C57Bl/6 
mice after 14 weeks of treatment while endothelium-dependent relaxation was markedly impaired 
in the high fat diet group.  After 21 weeks of the  high fat diet, endothelium-dependent relaxation 
was still  poorer as compared with normal fat fed mice. Preincubation with L-arginine, L-
norvaline, sepiapterin and Tiron markedly improved  maximal endothelium-dependent 
vasodilatation. CR significantly alleviated the blunted endothelium-dependent vasodilatation in 
obese mice. Endothelium-independent relaxation responses developed similarly between lean,               
obese and CR mice  (table 8).                                                                                                               .
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Table 7. Maximal relaxation and contraction responses (%) in isolated thoracic aortas from C57Bl/6 mice and from atherosclerotic prone 
mice fed high-salt diets in studies I-II. Comparisons have been done according to study design and results in original publications. 
 
Strain and diet C57Bl/6 + 
chow 
C57Bl/6 + 
high-NaCl 
C57Bl/6 + 
high-fat 
C57Bl/6 + 
high-fat+ 
high-NaCl 
ApoE-/- + 
chow 
ApoE-/- + 
high-
NaCl 
LDLR-/- + 
chow 
LDLR-/- + 
high-fat 
LDLR-/- + 
high-fat + 
high-NaCl 
Ach, 
maximal  
relaxation (%) 
 
 
84±4 
 
30±5a 
 
46±8a 
 
52±5 
 
26±5a 
 
25±3b 
 
56±6 
 
56±5 
 
35±7c 
Ach preincubated 
with Tiron;  
maximal  
relaxation (%) 
 
100±0 
 
100±1 
 
98±1 
 
99±1 
 
100±0 
 
100±1 
 
97±2 
 
98±1 
 
96±2 
SNP, 
maximal  
relaxation (%) 
 
97±1 
 
98±1 
 
99±1 
 
97±1 
 
98±1 
 
99±5 
 
100±0 
 
101±1 
 
95±1 
NA, 
precontraction (g) 
 
0.9±0.2 
 
1.4±0.1a 
 
0.7±0.1 
 
1.0±0.1 
 
1.0±0.3 
 
1.2±0.2 
 
0.6±0.2 
 
0.6±0.2 
 
0.8±0.2 
Data are expressed as means±SEM (n=6/group). a p<0.05 vs. C57Bl/6 + chow; b p<0.05 vs. ApoE-/- + chow; c p<0.05 vs. LDLR-/- + high-fat; ApoE-/- = apolipoprotein E-deficient; 
LDLR-/- = low density lipoprotein receptor deficient 
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Table 8.  Maximal relaxant responses to Ach and contractile response to NA in study III. 
Comparisons have been done according to study design and results in original publications. 
Data are expressed as means±SEM (n=6/group) a p<0.05 vs. normal-fat 14 w.; b p<0.05 vs. normal-fat 21 w.;  c   p<0.05 vs.  
high fat 21 w.; d p<0.05 vs.  high-fat 14 w.;  w.= weeks. 
In Study IV, contractile responses to KCl were similarly developed in normal and high fat fed 
C57Bl/6 mice regardless of the amount of PVAT. In normal fat fed mice, contractile responses to 
Phe were markedly attenuated by the presence of PVAT whereas this effect was completely lost in 
mice fed the high fat diet.  The presence of PVAT markedly impaired endothelium dependent 
vasodilatation in high fat fed mice whereas mice fed normal fat  diet showed unaltered relaxation 
to Ach in the presence of PVAT. In obese mice, PVAT-dependent impairment of endothelium-
mediated vasodilatation was significantly alleviated  after  preincubation  with either Tiron or  
PEG-catalase. In lean mice, preincubation with Carb-PTIO or with PEG-catalase significantly 
impaired Ach-stimulated vasodilatation in rings with intact PVAT. Endothelium-independent 
vasodilatation responses to SNP developed similarly between the aortas with PVAT and aortas 
with PVAT removed regardless of the treatment. Preincubation with Tiron improved the 
anticontractile effect of PVAT in C57Bl/6 mice fed the high fat diet. In high fat fed mice, neither  
pretreatment with Carb-PTIO nor with PEG-catalase  affected contractile responses to Phe in aortic 
rings with intact fat compared to rings with fat removed. In lean mice, preincubation with PEG-
catalase slightly but significantly attenuated PVAT dependent anticontractility while pre-treatment 
with Carb-PTIO or with Tiron did not restore the anticontractility mediated by PVAT (table 9).  
Strain and diet C57Bl/6 + 
normal-fat 
14 weeks 
C57Bl/6 + 
high-fat 14 
weeks 
C57Bl/6 + 
normal-fat 
21 weeks 
C57Bl/6 + 
high-fat 21 
weeks 
C57Bl/6 + 
high-fat 14 
weeks + CR  7 
weeks 
Ach, 
maximal 
relaxation (%) 
 
95±2 
 
68±8a 
 
88±3 
 
62±5b 
 
92±5c 
Ach, 
maximal 
relaxation (%) 
preincubated 
with Tiron 
 
98±2 
 
94±3d 
 
100±0 
 
97±2c 
 
100±0 
SNP, 
maximal 
relaxation (%) 
 
90±4 
 
96±3 
 
100±0 
 
92±3 
 
96±2 
NA, 
precontraction 
(g) 
 
0.21±0.1 
 
0.14±0.0 
 
0.34±0.1 
 
0.32±0.0 
 
0.25±0.0 
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Table 9. Maximal relaxant and contractile responses in isolated abdominal aortas with and 
without perivascular fat (PVAT) from diet-induced lean and obese C57Bl/6 in study IV. 
Strain and diet C57Bl/6 + 
normal-fat, 
PVAT(-) 
C57Bl/6 + 
high-fat, 
PVAT(-) 
C57Bl/6 + 
normal-fat, 
PVAT(+) 
C57Bl/6 + 
high-fat, 
PVAT(+) 
Maximal 
contraction to 
KCl (g) 
 
0.4±0.1 
 
0.5±0.1 
 
0.5±0.1 
 
0.4±0.1 
Maximal 
contraction to 
Phe (% of KCl) 
 
 
132±16 
 
83±11 
 
89±6a 
 
91±5 
Maximal Ach-
stimulated 
relaxation (%) 
after KCl  
 
13±5 
 
18±2 
 
25±4a 
 
12±3b 
Maximal Ach-
stimulated 
relaxation (%) 
after Phe  
 
80±5 
 
83±4 
 
73±3 
 
59±6b 
Maximal Ach 
relaxation (%) 
preincubated 
with Tiron  
 
81±3 
 
81±4 
 
76±5 
 
74±5d 
Maximal Ach 
relaxation (%) 
preincubated 
with PEG-
Catalase 
 
90±4 
 
86±8 
 
75±5 
 
71±6d 
Maximal Ach 
relaxation (%) 
preincubated 
with Carb-PTIO 
 
71±16 
 
64±4 
 
55±7c 
 
51±4 
Maximal SNP-
stimulated 
relaxation (%) 
 
97±2 
 
100±3 
 
94±5 
 
99±0 
Data are expressed as means± SEM (n=6-14/group). PVAT = periadventitital adipose tissue; (-) = removed; (+) = intact; a 
p<0.05 vs. normal-fat (PVAT-); b p<0.05 vs. high-fat (PVAT-); c p<0.05 vs. normal-fat (PVAT+) d p<0.05 vs. high-fat 
(PVAT+) 
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5.6 REACTIVE OXYGEN SPECIES FORMATION 
Vascular superoxide production 
In Study I, ApoE-/- mice receiving a normal salt diet had markedly elevated superoxide production 
as compared with C57Bl/6 mice (table 10). The high salt diet increased superoxide formation in 
both mice strains but more pronouncedly in ApoE-/- mice. In Study II, LDLR-/- mice on a normal fat 
diet showed significantly increased generation of superoxide as compared with C57Bl/6 mice. 
High cholesterol/high fat diet increased superoxide production in both strains but more 
pronouncedly in C57Bl/6 mice. The combination of high fat /high cholesterol and high salt diet 
increased further superoxide formation in both mice strains but more markedly in LDLR-/- mice. 
Preincubation with apocynin, L-NAME or endothelium removal markedly decreased superoxide 
generation while oxypurinol only slightly prevented this effect in LDLR-/- mice on combined high 
fat /high cholesterol and high salt diet. In C57Bl/6 mice on the combined high fat /high cholesterol 
and high salt diet, both L-NAME and endothelium removal markedly increased superoxide 
formation whereas  apocynin and oxypurinol  had no effects. Preincubation with Ach reduced 
aortic superoxide formation similarly  in  C57Bl/6 mice on high fat/high cholesterol and the 
corresponding mice on the  combined high  fat/ high cholesterol and high sodium diet. In LDLR-/- 
mice receiving the combined high fat/ high cholesterol and high sodium diet, preincubation with 
Ach reduced markedly less superoxide formation than seen in the corresponding mice on high  fat/ 
high cholesterol diet (table 10). In Study III, the high fat diet increased aortic superoxide 
production in  C57Bl/6 mice after both 14 weeks and 21 weeks of the treatment. Endothelium 
removal or  the preincubations with apocynin, oxypurinol and L-NAME led to a marked reduction 
in the overproduction of superoxide in obese mice after 21 weeks of consumption of high fat diet. 
CR  significantly decreased vascular production of superoxide in obese mice. In the mouse group 
with  CR endothelium removal caused marked increase in superoxide production whereas 
superoxide production remained unaltered after preincubation with L-NAME. In lean mice fed 
normal fat diet for 21 weeks, both endothelium removal and preincubation with L-NAME 
increased aortic superoxide formation. These mice also exhibited  no alterations in the superoxide 
generation after pretreatments with apocynin, oxypurinol or sepiapterin (table 11).  
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Table 10.  Superoxide levels in the aortas of mice fed high salt diet in studies I-II. Comparisons have been made according to original 
publications. 
Strain and diet C57Bl/6 
+ chow 
C57Bl/6 + 
high-NaCl 
C57Bl/6 
+ high-
fat 
C57Bl/6 + 
high-fat+ 
high-NaCl 
ApoE-/- + 
chow 
ApoE-/- + 
high-NaCl 
LDLR-/- + 
chow 
LDLR-/- + 
high-fat 
LDLR-/- + 
 high-fat + 
high-NaCl 
Vascular  
superoxide 
production 
(counts/mg/min) 
 
860 
±160 
 
3666 
±573a 
 
3858 
±459 
 
5430 
±517 
 
 
 
3540 
±438a 
 
5905 
±248b 
 
3956 
±425 
 
4881 
±627 
 
8586 
±1346c 
 
 
Vascular  
superoxide 
production 
preincubated  
with Ach 
(counts/mg/min) 
 
1249 
±360 
 
1069 
±144a 
 
1324 
±128 
 
1332 
±124d 
 
2300 
±337 
 
1994 
±357 
 
n.d. 
 
1753 
±377 
 
5307 
±798c 
          
Pre- 
treatment 
apocynin oxypurinol L-NAME endo 
removal 
Pre-
treatment 
apocynin oxypurinol L-NAME endo 
removal 
C57Bl/6 + high-
fat+ high-NaCl 
(counts/mg/min) 
6200 
±832 
4360 
±698 
8212 
±1059e 
16673 
±1773e 
LDLR-/- + 
high-fat 
+ high-NaCl 
(counts/mg
/min) 
5127 
±712f 
7324 
±1262 
3378 
±1009f 
3801 
±926f 
Data are expressed as means ± SEM (n=6/group). apoc= apocynin; oxyp = oxypurinol; endo= endothelium removal a p<0.05 vs.  C57Bl/6 mice on chow; b p<0.05 vs. ApoE-/- mice 
on chow;  c p<0.05 vs. LDLR-/- mice on high-fat; d p<0.05 vs.  C57Bl/6 mice + high fat; e p<0.05 vs.  C57Bl/6 mice on high-fat/high NaCl; f p<0.05 vs.  LDLR-/- mice on high-fat/high 
NaCl. 
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Table 11. Aortic production of superoxide after caloric restriction in diet induced obese and lean 
mice in study III. Comparisons have been made according to study III. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data are expressed as means ± SEM (n=6/group).  a p<0.05 vs. normal-fat; b  p< 0.05 vs. high-fat; c p<0.05 vs. CR  
nd = not determined 
 
 
 
 
 
Strain and diet C57Bl/6 + 
normal-fat 21 
weeks 
C57Bl/6 + 
high-fat 21 
weeks 
C57Bl/6 + 
high-fat 14 
weeks + CR 7 
weeks 
Vascular superoxide 
production 
(counts/mg/min) 
 
5198±395 
 
14968±1661a 
 
3866±192b 
Vascular superoxide 
production  after  L-NAME 
preincubation 
(counts/mg/min) 
 
9199±536a 
 
9457±1835b 
 
3391±438 
Vascular superoxide 
production after 
endothelium removal 
(counts/mg/min) 
 
8854±530 
 
81±81b 
 
5320±384c 
Vascular superoxide 
production after apocynin 
preincubation  
(counts/mg/min) 
 
5424±534 
 
6573±731b 
 
nd 
Vascular superoxide 
production after 
oxypurinol  preincubation 
(counts/mg/min) 
 
4023±505 
 
3686±1282b 
 
nd 
Vascular superoxide 
production after 
sepiapterin  
preincubation 
(counts/mg/min) 
5627±653 2112±270b nd 
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Perivascular fat derived superoxide and hydrogen peroxide production 
In Study IV, isolated PVAT samples obtained from obese mice displayed markedly more  
superoxide production compared to lean mice. H2O2  generation was also significantly  higher in 
obese than in lean mice. Preincubation with Ang II markedly enhanced  the  productions of 
superoxide and H2O2 in both mice groups while mice fed a  normal fat  diet showed slightly but 
significantly higher levels of both ROS. Pretreatment with apocynin significantly reduced both 
basal and angiotensin II stimulated superoxide formation in both mice strains (Table 12). 
 
Table 12. Superoxide and hydrogen peroxide formation in the PVAT samples from lean and 
obese C57Bl/6 mice in study IV. Comparisons have been made according to study IV. 
 
 
 
 
 
 
 
 
 
 
 
Data are expressed as means± SEM (n= 3-4/group). a p<0.05 vs. normal-fat;  b p<0.05 vs.  high-fat  
 
 
Strain and diet C57Bl/6 + 
normal-fat, 
PVAT 
C57Bl/6 +  
high-fat, 
 PVAT 
Basal superoxide 
generation 
(counts/mg/min) 
 
289±16 
 
567±19a 
Basal superoxide 
generation preincubated 
with apocynin 
(counts/mg/min) 
 
140±22 
 
108±10b 
Ang II stimulated 
superoxide generation 
(counts/mg/min) 
 
 
1322±45a 
 
1115±33b 
Ang II stimulated 
superoxide production 
preincubated with apocynin 
(counts/mg/min) 
 
 
27±1.5a 
 
60±0.3b 
Basal hydrogen peroxide 
production 
(counts/mg/min) 
 
 
400±85 
 
1095±222a 
Ang II stimulated  
hydrogen peroxide 
production  
(counts/mg/min) 
 
5066±341 
 
3313±265a 
 58 
5.7 TOTAL eNOS AND PHOSPHORYLATED eNOS PROTEIN EXPRESSION 
 
 In Study III, high fat feeding for 21 weeks increased aortic eNOS expression by 75% in obese mice 
and by 50%  in CR obese  compared to lean mice. However, only the value in obese mice reached 
statistical significance. Aortic p-eNOS expressions were comparable in all treatment groups. In 
obese mice, p-eNOS/eNOS ratio was markedly decreased by 45% as compared to the situation on  
lean controls, and non-significantly   (-23%) compared to CR mice. 
  
5.8  mRNA EXPRESSIONS OF ADIPOCYTOKINES AND NADPH OXIDASE 
 
In Study IV, obese mice had markedly increased mRNA expressions of leptin, MCP-1 and Ncf-2 
compared with lean mice while expression of adiponectin  remained  similar  between the groups. 
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6  Discussion 
According to many epidemiological studies, clinical interventions and experimental animal 
studies, the Western type diet, typically rich in cholesterol, saturated fat and sodium is crucially 
associated with impaired vascular function promoting the development of cardiovascular diseases 
(Hu & Willett 2002). However, the molecular mechanisms by which dietary factors modulate 
endothelial function, an early marker of atherosclerotic vascular disease, are only partially 
understood (Davis et al. 2007). This study investigated the effects of dietary intake of sodium on 
atherosclerosis, oxidative stress and endothelial function. The effects of CR and PVAT on 
endothelial dysfunction were also studied.   In the high salt studies, genetic mice models for 
atherosclerosis i.e.  ApoE-/- and LDLR-/- mice were used whereas C57Bl/6 mice were used as a strain 
which is genetically prone for human type diet-induced obesity.  
6.1 METHODOLOGY 
Mice models  
Despite being widely used and well-accepted murine model for the field of atherosclerosis 
research there are still some limitations associated with  the ApoE-/- mice. As compared with 
standard laboratory chow, which  augments plasma cholesterol levels by about 2-3 times above 
C57Bl/6 mice on corresponding diet, high fat/high cholesterol diets may induce even 10 times 
higher  total cholesterol in ApoE-/- mice.   Additionally, blood cholesterol is confined to VLDL 
rather than to LDL. Moreover, spontaneous plaque rupture is observed very rarely e.g.  only after 
robust prevention of NO-synthase or after blockade of scavenger receptors for cholesterol in 
macrophages (for review see Knowles & Maeda 2000; Meier & Leitersdorf   2004; Getzt  & Reardon  
2006). In turn, the LDLR-/- mouse resembles the  familiar hypercholesterolemia observed in human 
patients. Mice lacking the gene for LDL receptor display only modestly elevated levels of 
cholesterol and only slowly developing fatty lesions in proximal aorta and they require fat 
supplementation to induce atherosclerosis (Getz & Reardon 2006; Zadelaar et al. 2007). Exposure 
for high fat feeding leads to the development of atherosclerosis lesions comparable to the situation 
in  ApoE-/- mice. In summary, one can say that the  LDLR-/- mouse represents a more moderate 
model of atherosclerosis than   ApoE-/- mice predominantly due to lower cholesterol levels (Jawien 
et al. 2004; Wouters et al. 2005; Zadelaar et al. 2007). 
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Blood pressure measurements 
In the present study, arterial pressure was measured by the tail cuff method (Study I, II). The 
blood pressure values measured by the noninvasive tail cuff method are reproducible and and 
give values which are similar to those obtained with the invasive radiotelemetry with intra-arterial 
catheters (Krege et al. 1995). In addition to its many advantages related to technical simplicity and 
low cost, the tail cuff method  does not require anesthesia  or surgical implantation. However, the 
disadvantages of this method include the under or over-estimation of arterial pressure due to 
mouse  being place into plastic holders, prewarming to  a high temperature and the pressure of tail 
cuffs and noise (Whitesall et al. 2004). These potential stress-induced impacts on the behaviour of 
the mouse can be minimized by a period of pretraining of the mice, and ensuring that the same 
individual  regularly  performs the measurements in a semi-dark and peaceful environment. In the 
present study, blood pressure values acquired at daytime may be underestimated due to lack of 
measurements from the night-time period, when mice are awake, are active and have higher blood 
pressures. Thus, telemetric monitoring of arterial pressure would have provided more information 
about the natural course and included effects of circadian rhythm on blood pressure changes in 
mice.  
   
Aortic ring preparations 
The isolated aortic ring preparation is the classic way to investigate vascular reactivity in response 
to vasoconstrictors and vasodilators. Mouse aorta develops a stable precontraction in response to 
adrenergic agonists  which allows the determination of concentration dependent responses to 
vasodilatory agents (Zhou et al. 2005) Furchgott and Zawadzki using rabbit aortic rings were the 
first to show the obligatory role of the endothelium in the vasodilatory responses to Ach 
(Furchgott & Zawadzki 1980). Harrison and colleagues demonstrated the relation between 
hypercholesterolemia induced vascular oxygen free radical formation and defective endothelium-
dependent vasorelaxation (Ohara et al. 1993). Organ bath studies also allow the investigation of 
varying pretreatments with different enzyme inhibitors and ROS scavengers on vascular function.  
Additionally, an isolated blood vessel generates and secretes various hormones and vasoactive 
compounds into buffer solution which can be collected for further analysis. One is that  oxidative 
stress may be overestimated in this experimental setting due to the concentration high and 
continuous presence of  oxygen in the organ bath. Furthermore, the surrounding connective and 
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fat tissues are frequently removed during the vessel preparation which may have an impact on 
vascular reactivity. 
 
Diets 
In order to create a human-type of experimental hypertension, mice were fed high-salt diets. 
Currently, it has been estimated that salt consumption in human beings living in modern Western 
societies is about 10 times higher than the human genes programmed to deal with salt in the diet   
10 000 years ago in the Stone Age  (Frassetto  et al. 2001). Therefore, a high salt diet was 
manufactured by mixing NaCl into chow in order to achieve a high salt diet containing 7% of NaCl 
while normal salt diet contained 0.7- 0.8%. In previous studies, the blood pressure increasing effect 
has been demonstrated in laboratory animals consuming chow containing 4-8% NaCl (Gajda et al. 
2007).  The level of sodium intake in these dietary approaches is not toxic to experimental animals 
and does not cause any undesirable undernutrion or body weight loss.  A diet high in fat and in 
cholesterol, also called a Western type diet, is typically used to enhance serum cholesterol levels 
and accelerate the development of atherosclerosis in LDLR-/-   mice (Lichtman et al. 1999). Within 
12 weeks of consuming this Western type diet, the strain develops  atherosclerotic lesions in 
proximal aorta and also throughout the ascending and descending aortas (Lichtmann et al. 1999). 
In this thesis, a mixture of chow plus added fat was used to formulate a high fat/high cholesterol 
diet. Although this is a widely accepted way of manufacturing research diets, adding more and 
more fat into chow may lead to dilution of  other important nutrients such as proteins, vitamins, 
minerals and fiber (Gajda et al. 2007)  (Study I, II). C57Bl/6 mice develop obesity in response to 
high caloric intake typically from  saturated fat while other relevant experimental models of 
human obesity, including ob/ob mice or Zucker fatty rats exhibit obesity due to a single mutation 
in the  gene coding for leptin receptor or leptin expression, respectively (Collins et al. 2004; 
Speakman et al. 2008).  In C57Bl/6 mice, body weight gain leads to fatty liver and changes in 
metabolic parameters e.g. mildly elevated levels of serum cholesterol, hyperglycemia and insulin 
resistance (Parekh et al. 1998). CR was carried out by  reducing the average daily ad libitum energy 
intake by 30% which maintains physiological growth and animal well-being and thus can be 
considered as an ethical, relevant and safe way to induce weight loss in  mice (Keenan et al. 1998) 
(Study III, IV). 
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Vascular reactive oxygen species measurements 
In the present study, vascular oxidative stress was measured based on the superoxide production 
from the aortic ring preparation. Additionally, in order to investigate the free oxygen radical 
formation from PVAT samples, the luminol enhanced chemiluminescence technique was used.  
Both chemiluminescence techniques are well-established ways to selectively semiquantify  ROS 
production. These bioassays have several advantages, i.g. they are low cost, rather simple and do 
not require long term periods to  perform (Cai et al. 2007). On the other hand, the size of the tissue 
(e.g. blood vessel, fat) samples should be equal and the superoxide production is normalized 
according to vessel wet or dry weight or protein content. Additionally, a specific pharmacological 
scavenger should be chosen based on its high cell-permeability to allow quenching of  free oxygen 
radicals in both extra and intracellular compartments.  Superoxide reacts with lucigenin which 
then forms a radical which can be  detected as  light emission in a luminator. However, there has 
been much debate about  whether lucigenin itself might generate oxygen free radicals. According 
to recent studies lucigenin concentrations between 5-50 µmol/L do not generate artificial 
superoxide formation (Cai et al. 2007). Collectively, in this study superoxide production was 
measured using 5 µmol/L lucigenin or 250 µmol/L luminol and the reactive oxygen species  
formation was normalized according to tissue weight (Study I-IV). 
 
6.2 HIGH SALT INTAKE AND VASCULAR DYSFUNCTION (Studies I-II) 
 
In this series of studies,  high salt feeding to atherosclerosis prone rodents, i.e.  ApoE-/- and  LDLR-/- 
mice, resulted in  increased blood pressure, atherosclerosis, cardiac hypertrophy and kidney 
damage.  As a marker of vascular dysfunction, a high salt diet induced defective endothelium-
dependent vasodilatation in response to cholinergic receptor stimulation, while endothelium-
independent relaxation responses to SNP and the degree of pre-constriction to NA were preserved. 
Impaired aortic endothelium-mediated vasodilatation was markedly improved after pre-treatment 
with the superoxide scavenger, Tiron. Feeding a high salt diet  led also to increased vascular 
superoxide formation via NADPH oxidase and uncoupled eNOS.  These results  indicate that high 
salt diet promotes  vascular dysfunction via increased oxidative stress, which at least in part 
promotes endothelial dysfunction. These results corroborate previous studies suggesting that 
abnormal vascular function in both conduit and resistance arteries is a typical and early finding 
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after increased salt intake in  models of normotensive and  hypertensive rodents (Lenda et  al. 
2000; Ma et al. 2001; Smith  et al. 2003; Zhou et al. 2003; Yu  et al. 2004). Importantly, a high salt diet  
induced a similar phenotype in wild-type C57Bl/6 mice suggesting that high serum cholesterol 
levels are not prerequisite for the adverse cardiovascular effects observed after high salt intake. 
Collectively, the findings of this study highlight  the detrimental effects of high salt intake on 
vascular function, independent of serum cholesterol levels  and emphasize the pivotal role of 
increased oxidative stress in the pathogenesis of vascular disorders.   
 
Earlier studies have also  raised the possibility that eNOS derived superoxide formation could 
contribute to the  vascular and systemic oxidative stress encountered with a  high salt diet (Ma et 
al. 2001; Bayorh et al. 2004, Zhou et al. 2003). It has also been    speculated  that this link could be 
mediated via increased levels of  oxLDL, facilitating  vascular superoxide generation from 
NADPH oxidase, thereby leading to uncoupled eNOS (Galle  et al. 2006). In accordance with this 
theory, salt induced vascular superoxide formation was more pronounced in hypercholesterolemic 
and atherosclerotic mice compared with normocholesterolemic C57Bl/6 mice. Hence, it is possible 
that hypercholesterolemia and increased salt intake might increase oxLDL cholesterol in the 
vascular wall of atherosclerotic mice promoting vascular dysfunction. Furthermore the  vascular 
superoxide generation induced by the high salt diet was  decreased by pre-treatments with  L-
NAME and apocynin  and endothelium removal.  Pretreatment of vascular ring segments with L-
NAME and mechanical rubbing of endothelial cell layer  are widely accepted and simple 
techniques to gain  insights into the involvement of the role of uncoupled eNOS (Munzel et al. 
2005). On the other hand, apocynin is a widely used pharmacological agent to suppress NADPH 
oxidase derived ROS formation. However, L-NAME is a non-selective NOS inhibitor,  preventing 
the  physiological  enzyme function of iNOS and nNOS, which may both influence superoxide 
formation. Moreover, apocynin inhibits NADPH oxidase but may also have direct scavenging 
properties on superoxide anions and  other potential free oxygen radicals (Stefanska & Pawliczak 
2008). An investigation of the monomer/dimer ratio of eNOS and tetrahydrobiopterin levels would 
have helped clarify the mechanism behind these findings. 
 
The present study supports the previous epidemiological  and experimental findings that a high 
sodium intake is a pertinent risk factor for elevated arterial pressure, increased left ventricular 
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hypertrophy and renal dysfunction (Meneton  et al. 2005; Karppanen  & Mervaala  2006). One  
important observation emerging from this study was the  additive effect of high salt intake and 
genetic predisposition to atherosclerosis resulting in increased  systolic blood pressure, cardiac 
hypertrophy and kidney damage. Enhanced total mass of cardiac muscle is typically considered to 
be due to left ventricular hypertrophy (LVH) which is  directly linked to elevated arterial pressure. 
Cardiac hypertrophy caused by LVH is also a powerful predictor of adverse cardiovascular 
outcomes in normotensive populations (Gradman  & Alfayoumi 2006). The finding that ApoE-/- 
mice on normal chow diet exhibited increased heart-weight-to body weight ratio suggests that also 
some other mechanism in addition to  sodium induced hypertension and/or hypertropic effects 
might also contribute to the cardiac hypertrophy in this strain (Hartley et al. 2000).  
 
The issue of salt sensitivity is complex and only partially understood.  The current concept  
describes  a pertinent role for acquired renal microvascular and tubulointerstitial injury 
predisposing to the development of salt-sensitive hypertension in experimental and human studies 
(Johnson et al. 2005). It is noteworthy, that the progression of atherosclerosis in both ApoE-/- and 
LDLR-/- mice is associated with kidney dysfunction as characterized by glomerular lesions and 
lipid deposits filling the glomerular capillaries (Wen et al. 2002; Qiao et al. 2009). In the current 
study, the elevation in blood pressure encountered with high salt diet was pronounced  in  
hypercholesterolemic mice which also showed severe  kidney hypertrophy accompanied by  
hyperalbuminuria. Augmented albuminuria is considered as an important cardiovascular risk 
marker of  abnormal kidney function due to impaired glomerular capillary permeability (Futrakul 
et al. 2009). In a rat model of diet-induced obesity, a high sodium diet has  increased oxidative 
stress in the kidney this being  accompanied by kidney glomerulosclerosis and microalbuminuria 
(Dobrian  et al. 2003). Therefore, it is possible that the changes occuring in kidney function in 
atherosclerotic mice promoted the increased salt sensitivity observed in this study.   
 
The mechanistic link between increased dietary salt and endothelial dysfunction is still a matter of 
debate and open to  speculation. There is evidence that high salt ingestion although attenuating the 
systemic Ang II levels may have many other detrimental effects e.g. enhancing local upregulation 
of this powerful paracrine mediator (Zhou et al. 2003a); down-regulating renal and vascular eNOS 
expression (Ni  & Vaziri  2001);  decreasing L-arginine conversion to NO in the renal vascular 
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endothelium in hypertensive patients (Higashi  et al. 1996) up-regulating  the endogenous 
inhibitor of eNOS synthase, ADMA, which contributes to decreased NO levels in mildly 
hypertensive patients (Fujiwara et al. 2000). In the recent study of  Oberleithner et al. (2007),  it was 
demonstrated that there is a causative link between extracellular sodium and vascular endothelial 
morphodynamics. In particular, those investigators used, human EC culture to demonstrate that 
high extracellular sodium concentration in conjuction with aldosterone stiffened endothelial cells 
and reduces NO release from the vascular endothelium (Oberleithner et al. 2007). Secondary to 
increasing ROS formation and accentuating protein and DNA oxidation, a high concentration of 
extracellular sodium promotes cellular signs of senescence such as a decreased rate of 
proliferation, elevated  beta-galactosidase activity and increased expression of proteins promoting 
cell cycle arrest (Dmitrieva & Burg  2007). 
 
To sum up, these results indicate that 1) the detrimental actions of high sodium feeding on 
vascular function are due to endothelium-dependent oxidative stress resulting in diminished NO 
bioavailability 2) high salt intake and hyperlipidemia has an additive effect on vascular oxidative 
stress 3) high sodium intake in combination with high fat/high cholesterol diet  is associated with   
augmented levels of  superoxide anions from uncoupled eNOS and/ or from NADPH-oxidase. 
 
6.3 OBESITY  AND  VASCULAR DYSFUNCTION   (Studies III-IV) 
Effects of caloric restriction on endothelial dysfunction 
C57Bl/6 mice fed a high fat diet displayed  a phenotype of obesity characterized by adipose tissue 
accumulation, hyperglycemia and increased oxLDL cholesterol. CR completely ameliorated these 
metabolic disturbances in these obese mice.  Obesity induced vascular dysfunction was 
characterized by decreased endothelium-dependent vasodilatation associated with increased 
vascular superoxide formation.  In line with earlier studies, obesity in C57Bl/6 mice is associated 
with vascular dysfunction due to impaired endothelium-dependent vasodilatation, enhanced 
sensitivity to contractile agents and excess production of ROS in the vascular wall (Molnar et al. 
2005; Noronha et al. 2005; Traupe  et al. 2002a; Mundy  et al. 2007; Traupe  et al. 2002b;  Kim  et al. 
2008; Symons  et al. 2009). Clinical studies have demonstrated that even a single high fat meal can 
acutely decrease brachial artery diameter and that consuming a high fat diet for 3 weeks results in 
endothelial dysfunction (Vogel et al. 1997; Keogh et al. 2005). 
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Obesity induced endothelial dysfunction could be  corrected by pretreatment with several 
compounds e.g. L-arginine, sepiapterin, L-norvaline and Tiron. These results supported the 
concept  that obesity impairs NO-dependent vasodilatation,  possibly by  augmenting superoxide 
formation through eNOS. There is emerging experimental evidence demonstrating  that in 
atherosclerosis, diabetes and hypertension, vascular eNOS is often uncoupled due to the 
insufficient bioavailability of BH4 due to oxidative stress (Förstermann & Munzel 2006). The 
uncoupling of eNOS means that superoxide formation prevails over NO production.  However, 
the precise molecular mechanism to explain the insufficient  NO bioavailability in obesity  is only 
partially understood. It has been proposed that obesity can trigger a relative deficiency of the 
cofactor BH4 and substrate L-arginine thereby decreasing NO production and activation of eNOS 
(Avogaro & de Kreutzenberg  2005).  Obese C57Bl/6 mice fed a high fat diet for 3 months displayed  
decreased levels of vascular L-arginine whereas the oxidative products of BH4 7,8-
dihydrobiopterin and biopterin were markedly enhanced (Korda  et al. 2008). In particular, in 
C57Bl/6 mice, 85% of  the BH4 content is derived from endothelium as compared with 
atherosclerotic ApoE-/- mice which show also relatively large BH4 sources in smooth muscle cells 
(Landmesser et al. 2003; d´Uschio & Katusic  2006).  Additionally, hypercholesterolemia may 
increase vascular endothelial cell expression of arginase II which  by  competing for L-arginine 
with eNOS, may have reduced  NO production (Ryoo et al. 2008).  
 
In this study, vascular superoxide formation was derived from the endothelium and from enzyme 
sources pointing to a role for  uncoupled eNOS, NADPH-oxidase and xanthine oxidase.   
Collectively, there appeared to be a complex interplay between the different enzyme sources 
responsible for vascular reactive oxygen species formation in  experimentally induced obesity. 
Recent reports suggest that a diet-induced metabolic syndrome promotes an   imbalance between 
pro-oxidant and antioxidant enzymes e.g. upregulation of NADPH oxidase  and downregulation 
of SOD isoforms, glutathione peroxidase and HO-2 in the vasculature (Roberts et al. 2006). In a 
recent study with rats fed a high fat diet, XO activation  was linked to increased superoxide 
production in carotid arteries while marked XO immunostaining was detected in the ECs of 
gracilis arteries of obese rats (Erdei  et al. 2006). Noronha and co-workers (Noronha et al. 2005)  
demonstrated that aortic ring preincubation with Ach increased ROS formation in obese mice 
which they interpret as being due to  eNOS derived oxidative stress. Therefore, further studies are 
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needed to elucidate enzyme sources for superoxide formation  in the pathogenesis of obesity 
induced endothelial dysfunction. 
 
In the present study, the obesity was associated with a decreased ratio between phosphorylated 
eNOS at its active site and total eNOS expression. Thus, obese C57Bl/6 mice exhibit both 
dysregulation of eNOS phosphorylation and eNOS uncoupling which are integrally linked to 
reductions in NO bioavailability. However, it is unclear whether or not  increased superoxide 
formation is due to the eNOS dimer/monomer ratio  and/or to   changes in the expression of other 
potential NO producing enzymes iNOS and nNOS  (Förstermann & Munzel 2006). 
 
One important finding of this study was that CR could fully reverse the detrimental effects of diet-
induced obesity on endothelial dysfunction and vascular oxidative stress. CR normalized also the 
expression of eNOS and the ratio between phosphorylated and total eNOS expression.   In fact, a 
reduced dietary energy intake in clinical and observational has achieved  similar metabolic 
adaptations and led to reductions in many of the risk factors for cardiovascular diseases  (Fontana 
& Klein  2007). However the exact molecular mechanism beyond the  beneficial vascular effect 
achieved  by CR remains  to be  elucidated.   In rodent models of aging,  chronic energy restriction 
has significantly improved endothelial function, attenuated vascular ROS production, inhibited 
NF-kappaB activity and down-regulated inflammatory genes (Csiszar  et al. 2009).  In diabetic rats,  
CR is associated with  improved hyperglycemia and dyslipidemia as well as improved vascular 
NO-cGMP pathway, enhanced antioxidant defence system and  reduced vascular ROS formation 
(Minamiyana  et al. 2007). In hypercholesterolemic rats, reintroduction of a low cholesterol diet  
resulted in a significant normalization of blood pressure, serum lipid profile, contractile responses  
and endothelium-dependent relaxation which was linked to augmented influence  of EDHF  
(Ashraf et al. 2007). In conclusion, the current study  points to   a pathological role for uncoupled 
eNOS in obesity induced endothelial dysfunction and oxidative stress which can be corrected by  
CR.  
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Periadventitial adipose tissue-induced vascular dysfunction 
In recent years, experimental studies have increasingly recognized PVAT as a pivotal endocrine 
organ generating and secreting biologically active substances that transduce signals to adjacent 
blood vessels. (Gao et al. 2007a; Rajsheker et al. 2010). In vascular function studies, healthy PVAT  
contributes to anticontractile effect of vascular smooth muscle cells in response to various 
contractile agents (Rajsheker et al. 2010).  In  different models of obesity, in the setting of 
lipoatrophy or in   SHR rats changes in the PVAT  are associated with vascular dysfunction. 
(Galvez-Prieto et al. 2008; Rajsheker et al. 2010). Furthermore, dysregulation of local secretion of 
vasoactive and inflammatory adipose tissue derived molecules appear to play an important role 
for vascular pathophysiology (Heinrichot et al. 2005; Chatterjee  et al. 2009). There is experimental 
evidence to suggest that both  obesity and aging  impair physiological vasomodulation of PVAT by  
decreasing anticontractile properties, contributing to smooth muscle cell proliferation, augmenting 
chemotaxis and inflammation and increasing other key mediators of atherosclerosis (Barandier  et 
al. 2005;  Fesus  et al. 2007; Greenstein  et al. 2009). 
 
This study confims earlier reports that PVAT  promotes anticontractility  in lean mice (Gao et al. 
2007b). Another important finding was that obese aortas with PVAT exhibited  endothelial 
dysfunction and impaired anticontractile function relative to obese aortas where the  PVAT had 
been removed. Therefore, these results indicate that obesity could promote endothelial dysfunction 
via PVAT.  Obese PVAT dependent endothelial dysfunction and blunted anticontractility were 
improved by decreasing ROS formation after Tiron pretreatment. As compared with lean mice,  
isolated  PVAT samples obtained from  obese mice displaye higher production of superoxide and 
H2O2  associated with increased expression of  gene encoding for NADPH oxidase. The increased 
production of superoxide anions was ameliorated by apocynin, an inhibitor of NADPD oxidase. 
Collectively, extensive accumulation of PVAT associated with increased oxidative stress was likely 
to have provoked the  impaired anticontractility and endothelial dysfunction. It has been  
previously demonstrated that PVAT can enhance the  contractile response  by perivascular nerve 
activation elicited by electrical field stimulation. This facilitates the  release of PVAT derived 
superoxide anions  and this  is mediated by functional NADPH oxidase expression in rat 
mesenteric fat (Gao  et al. 2006). Greenstein and co-workers have shown that obese humans  
exhibit an impaired anticontractile effect due to increased PVAT derived ROS formation 
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(Greenstein et al. 2009). Furthermore, in the PVAT  of New Zealand obese mice, a model for the 
metabolic syndrome, increased expresion and activity of NADPH oxidase and decreased 
expression of SOD parallels the  vascular dysfunction and  the extent of uncoupled eNOS 
(Marchesi et al. 2009). Thus, these results emphasize  the important role of PVAT derived oxidative 
stress in the pathogenesis of endothelial dysfunction in obese C57Bl/6 mice.   
 
An attractive hypothesis raised by earlier studies is that local generation and secretion of adipocyte 
derived hormones, referred to adipokines, or other biologically active molecules might have 
affected vasomodulation (Rajsheker et al. 2010; Guzik et al. 2007). In type 2 diabetic rats, 
abrogation of the formation of the endogenous cytokine production could restore  endothelial 
dysfunction (Nishimatsu et al. 2008). Greenstein and co-authors  proposed that local hypoxia in  
PVAT in obese human patients could lead to the generation of inflammatory cytokines which in 
turn would deteriorate the physiological vasomodulation of  PVAT via oxidative stress 
(Greenstein et al. 2009).  In line with these earlier reports, it was found here, that obesity could lead 
to increased mRNA expression of proinflammatory cytokines leptin and MCP-1 in the PVAT while 
the levels of adiponectin remained  similar in obese and lean mice. These results also support for 
recent observations that inflammatory changes in the PVAT may have a direct role in the  
pathogenesis of accelerated vascular remodelling  due to  obesity (Takaoka et al. 2009).  
 
Perspectives 
Dietary factors in terms of modified diets or simply CR play an important role in the maintenance 
of  optimal cardiovascular health (Dauchet et al. 2009). For example, a two year close adherence to 
low-fat, Mediterranean or low-carbohydrate diets can all independently induce regression of 
carotid atherosclerosis and this was   strongly associated with decreased arterial pressure levels 
occuring in these subjects (Shai et al. 2010). The results of this thesis suggest that a  Western type 
diet  with its high content of  salt and  fat predisposes the individual to endothelial dysfunction, a 
condition  known to  sensitize  blood vessels to atherosclerotic vascular disease.  Thus, the results 
of this thesis  highlight the importance of dietary factors in the prevention of cardiovascular 
diseases. 
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In this thesis, oxidative stress was found to be a potential  molecular mechanism causing vascular 
damage through endothelial dysfunction. However, the expression and/or activity of the  
antioxidant systems were not addressed in the experimental conditions. In addition, the 
degree/magnitude of oxidative stress  needed to  cause endothelial dysfunction was only partially 
investigated. It is noteworthy that  ROS are physiological mediators strictly controlled by the 
actions of several  antioxidant enzymes in extra- and intracellular compartments (Blagosklonny 
2008). There is also experimental evidence that in certain conditions, a short-term oxidative stress 
may even benefit cell function and extend life span (Schulz et al. 2007). Therefore, in order to gain 
a better understanding of dietary mediated actions on vascular function, a more careful assessment 
of oxidative stress and the contributory role of antioxidant system would be  interesting topics for  
the future studies. Interestingly, in rats fed high-fat diet, high-salt intake increases the size of 
adipocytes and reduces their number (Dobrian et al. 2003). Therefore, it would be intriguing to 
determine whether a high salt diet alone or in combination with high fat diets can  alter PVAT 
function/structure and whether these alterations  subsequently impact on vascular function. 
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7  Summary and Conclusions  
 
In this thesis, molecular mechanisms of vascular dysfunction were investigated in diet-induced 
hypertension and obesity. The results are in line with the previous literature emphasizing  the 
detrimental effects of high salt and high fat intake, typical of a  Western diet.  The results of this 
thesis highlight the importance of vascular oxidative stress in the pathogenesis of endothelial 
dysfunction (see figure 7).    
The major conclusions are as follows. 
1. High salt intake can increase blood pressure and induce endothelial dysfunction and 
progression of atherosclerosis in two different widely-used murine models of human 
atherosclerosis. The detrimental effects of high salt intake on endothelial function are mediated by 
increased formation of ROS in the vascular wall by uncoupled eNOS and NADPH oxidase. 
2. Weight loss by CR can reverse experimental obesity-induced endothelial dysfunction. The 
beneficial vascular effects of CR are associated with decreased vascular superoxide formation by 
uncoupled eNOS.  
3. PVAT promotes endothelial dysfunction in an experimental model of human obesity via 
mechanisms that are linked to elevated  NADPH oxidase-derived oxidative stress and increased 
production of proinflammatory cytokines. 
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Figure 7. Schematic representation of the main mechanisms of vascular dysfunction in this 
thesis. 
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TAKAKANNEN YHTEENVETO TEKSTI 
 
The ultimate mechanisms of cardiovascular diseases remain unknown but the dietary factors in the 
pathogenesis of both hypertension and obesity are thought to be important. This study was 
designed to investigate the diet-induced vascular dysfunction in mice with a special emphasis on 
endothelium, reactive oxygen species and periadventitial fat. The results highlighted the 
importance of Western diet in the induction of hypertension and obesity predisposing to 
endothelial dysfunction and vascular oxidative stress.  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
